{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:25:29Z","timestamp":1793467529494,"version":"4.5.0"},"reference-count":431,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Projects from Wuhan Municipal Health Commission (WZ24B17) and TaiKang Healthcare Research Fund"},{"name":"he Key R&D Program of Hubei Province for International Cooperation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02820-3","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:02:19Z","timestamp":1787616139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cancer-associated adipocytes: metabolic reprogramming, crosstalk and therapeutic implications in tumor progression"],"prefix":"10.1038","volume":"11","author":[{"given":"Jinmin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa","family":"Abdel-Ghany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Abdel-Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Hassan Soliman","family":"Wadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Sabit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"2820_CR1","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1210\/endrev\/bnad015","volume":"44","author":"KA Brown","year":"2023","unstructured":"Brown, K. A. & Scherer, P. E. Update on adipose tissue and cancer. Endocr. Rev. 44, 961\u2013974 (2023).","journal-title":"Endocr. Rev."},{"key":"2820_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1158\/0008-5472.CAN-23-1641","volume":"84","author":"S Kim","year":"2024","unstructured":"Kim, S. et al. FAM3C in cancer-associated adipocytes promotes breast cancer cell survival and metastasis. Cancer Res. 84, 545\u2013559 (2024).","journal-title":"Cancer Res."},{"key":"2820_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48179-3","volume":"15","author":"Y Song","year":"2024","unstructured":"Song, Y. et al. Dysfunctional adipocytes promote tumor progression through YAP\/TAZ-dependent cancer-associated adipocyte transformation. Nat. Commun. 15, 4052 (2024).","journal-title":"Nat. Commun."},{"key":"2820_CR4","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/ijc.34859","volume":"154","author":"I Rybinska","year":"2024","unstructured":"Rybinska, I. et al. SAA1-dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness. Int. J. Cancer 154, 1842\u20131856 (2024).","journal-title":"Int. J. Cancer"},{"key":"2820_CR5","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.7150\/ijbs.65227","volume":"18","author":"C Zhou","year":"2022","unstructured":"Zhou, C. et al. Cancer-associated adipocytes promote the invasion and metastasis in breast cancer through LIF\/CXCLs positive feedback loop. Int. J. Biol. Sci. 18, 1363\u20131380 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"2820_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113001","volume":"141","author":"J Huang","year":"2024","unstructured":"Huang, J. et al. Rhein and hesperidin nanoparticles remodel tumor immune microenvironment by reducing CAFs and CCL2 secreted by CAAs for efficient triple-negative breast cancer therapy. Int. Immunopharmacol. 141, 113001 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"2820_CR7","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1111\/cas.14527","volume":"111","author":"M Takehara","year":"2020","unstructured":"Takehara, M. et al. Cancer-associated adipocytes promote pancreatic cancer progression through SAA1 expression. Cancer Sci. 111, 2883\u20132894 (2020).","journal-title":"Cancer Sci."},{"key":"2820_CR8","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1158\/0008-5472.CAN-23-2613","volume":"84","author":"JA Waters","year":"2024","unstructured":"Waters, J. A. et al. Omental preadipocytes stimulate matrix remodeling and IGF signaling to support ovarian cancer metastasis. Cancer Res. 84, 2073\u20132089 (2024).","journal-title":"Cancer Res."},{"key":"2820_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70265","volume":"13","author":"K Noda","year":"2024","unstructured":"Noda, K. et al. Exosomal miR-199a-3p secreted from cancer-associated adipocytes promotes pancreatic cancer progression. Cancer Med. 13, e70265 (2024).","journal-title":"Cancer Med."},{"key":"2820_CR10","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1158\/0008-5472.CAN-23-0505","volume":"83","author":"C Bouche","year":"2023","unstructured":"Bouche, C. & Quail, D. F. Fueling the tumor microenvironment with cancer-associated adipocytes. Cancer Res. 83, 1170\u20131172 (2023).","journal-title":"Cancer Res."},{"key":"2820_CR11","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.cmet.2021.08.012","volume":"33","author":"G Wei","year":"2021","unstructured":"Wei, G. et al. The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy. Cell Metab. 33, 2021\u20132039.e2028 (2021).","journal-title":"Cell Metab."},{"key":"2820_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06230-z","volume":"14","author":"R Huang","year":"2023","unstructured":"Huang, R. et al. Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy. Cell Death Dis. 14, 703 (2023).","journal-title":"Cell Death Dis."},{"key":"2820_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/21623945.2022.2108558","volume":"11","author":"A Liu","year":"2022","unstructured":"Liu, A. et al. Cancer cell-derived exosomal miR-425-3p induces white adipocyte atrophy. Adipocyte 11, 487\u2013500 (2022).","journal-title":"Adipocyte"},{"key":"2820_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32106","volume":"10","author":"Y Dong","year":"2024","unstructured":"Dong, Y., Bai, J. & Zhou, J. Developing a dormancy-associated ECM signature in TNBC that is linked to immunosuppressive tumor microenvironment and selective sensitivity to MAPK inhibitors. Heliyon 10, e32106 (2024).","journal-title":"Heliyon"},{"key":"2820_CR15","first-page":"2537","volume":"42","author":"Z Cai","year":"2019","unstructured":"Cai, Z. et al. Cancer\u2011associated adipocytes exhibit distinct phenotypes and facilitate tumor progression in pancreatic cancer. Oncol. Rep. 42, 2537\u20132549 (2019).","journal-title":"Oncol. Rep."},{"key":"2820_CR16","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","volume":"71","author":"B Dirat","year":"2011","unstructured":"Dirat, B. et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 71, 2455\u20132465 (2011).","journal-title":"Cancer Res."},{"key":"2820_CR17","doi-asserted-by":"publisher","first-page":"e0174126","DOI":"10.1371\/journal.pone.0174126","volume":"12","author":"J Lee","year":"2017","unstructured":"Lee, J. et al. Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism. PLoS One 12, e0174126 (2017).","journal-title":"PLoS One"},{"key":"2820_CR18","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.18632\/oncotarget.2012","volume":"5","author":"C Tebbe","year":"2014","unstructured":"Tebbe, C. et al. Metformin limits the adipocyte tumor-promoting effect on ovarian cancer. Oncotarget 5, 4746\u20134764 (2014).","journal-title":"Oncotarget"},{"key":"2820_CR19","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1039\/C5FO00478K","volume":"6","author":"L Du","year":"2015","unstructured":"Du, L. et al. EPA-enriched phospholipids ameliorate cancer-associated cachexia mainly by inhibiting lipolysis. Food Funct. 6, 3652\u20133662 (2015).","journal-title":"Food Funct."},{"key":"2820_CR20","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1182\/blood.2021013832","volume":"139","author":"C Panaroni","year":"2022","unstructured":"Panaroni, C. et al. Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins. Blood 139, 876\u2013888 (2022).","journal-title":"Blood"},{"key":"2820_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 33, 1001\u20131012.e1005 (2021).","journal-title":"Cell Metab."},{"key":"2820_CR22","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors. Immunity 54, 1561\u20131577.e1567 (2021).","journal-title":"Immunity"},{"key":"2820_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33349-y","volume":"13","author":"P Yang","year":"2022","unstructured":"Yang, P. et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat. Commun. 13, 5782 (2022).","journal-title":"Nat. Commun."},{"key":"2820_CR24","doi-asserted-by":"publisher","first-page":"E1068","DOI":"10.1152\/ajpendo.00473.2020","volume":"320","author":"A Raajendiran","year":"2021","unstructured":"Raajendiran, A. et al. Proteome analysis of human adipocytes identifies depot-specific heterogeneity at metabolic control points. Am. J. Physiol. Endocrinol. Metab. 320, E1068\u2013e1084 (2021).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2820_CR25","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1182\/blood-2013-03-489468","volume":"122","author":"S Tung","year":"2013","unstructured":"Tung, S. et al. PPAR\u03b1 and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia. Blood 122, 969\u2013980 (2013).","journal-title":"Blood"},{"key":"2820_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.21","volume":"8","author":"YA Wen","year":"2017","unstructured":"Wen, Y. A. et al. Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer. Cell Death Dis. 8, e2593 (2017).","journal-title":"Cell Death Dis."},{"key":"2820_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ogc.2018.07.008","volume":"45","author":"HM Kravitz","year":"2018","unstructured":"Kravitz, H. M., Kazlauskaite, R. & Joffe, H. Sleep, health, and metabolism in midlife women and menopause: food for thought. Obstet. Gynecol. Clin. North Am. 45, 679\u2013694 (2018).","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"2820_CR28","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.ccell.2023.05.010","volume":"41","author":"M Rask-Andersen","year":"2023","unstructured":"Rask-Andersen, M. et al. Adiposity and sex-specific cancer risk. Cancer Cell 41, 1186\u20131197.e1184 (2023).","journal-title":"Cancer Cell"},{"key":"2820_CR29","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jfda.2017.12.007","volume":"26","author":"CH Chang","year":"2018","unstructured":"Chang, C. H., Chang, Y. T., Tseng, T. H. & Wang, C. J. Mulberry leaf extract inhibit hepatocellular carcinoma cell proliferation by depressing IL-6 and TNF-\u03b1 derived from adipocyte. J. Food Drug Anal. 26, 1024\u20131032 (2018).","journal-title":"J. Food Drug Anal."},{"key":"2820_CR30","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/oby.24013","volume":"32","author":"D Frasca","year":"2024","unstructured":"Frasca, D. et al. Adipocyte-derived inflammatory molecules induce senescent B cells through metabolic pathways. Obesity 32, 1441\u20131447 (2024).","journal-title":"Obesity"},{"key":"2820_CR31","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12013-014-9980-x","volume":"70","author":"LL Xu","year":"2014","unstructured":"Xu, L. L. et al. TNF-\u03b1, IL-6, and leptin increase the expression of miR-378, an adipogenesis-related microRNA in human adipocytes. Cell Biochem. Biophys. 70, 771\u2013776 (2014).","journal-title":"Cell Biochem. Biophys."},{"key":"2820_CR32","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1210\/jc.2003-031804","volume":"89","author":"C Mantzoros","year":"2004","unstructured":"Mantzoros, C. et al. Adiponectin and breast cancer risk. J. Clin. Endocrinol. Metab. 89, 1102\u20131107 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2820_CR33","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2310\/JIM.0b013e3181cf91ca","volume":"58","author":"J Smiechowska","year":"2010","unstructured":"Smiechowska, J. et al. Adipokines in patients with cancer anorexia and cachexia. J. Investig. Med. 58, 554\u2013559 (2010).","journal-title":"J. Investig. Med."},{"key":"2820_CR34","doi-asserted-by":"crossref","unstructured":"Yum, C. et al. 1\u03b1,25-Dihydroxyvitamin D downregulates adipocyte impact on breast cancer cell migration and adipokine release. Nutrients 16, (2024).","DOI":"10.3390\/nu16183153"},{"key":"2820_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cmet.2018.05.005","volume":"28","author":"H Iwamoto","year":"2018","unstructured":"Iwamoto, H. et al. Cancer lipid metabolism confers antiangiogenic drug resistance. Cell Metab. 28, 104\u2013117.e105 (2018).","journal-title":"Cell Metab."},{"key":"2820_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41586-022-05030-3","volume":"608","author":"T Seki","year":"2022","unstructured":"Seki, T. et al. Brown-fat-mediated tumor suppression by cold-altered global metabolism. Nature 608, 421\u2013428 (2022).","journal-title":"Nature"},{"key":"2820_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2025.114573","volume":"448","author":"B Guo","year":"2025","unstructured":"Guo, B. et al. Runx1 activates the transformation of adipocytes into cancer-associated adipocytes by downregulating Plin1. Exp. Cell Res. 448, 114573 (2025).","journal-title":"Exp. Cell Res."},{"key":"2820_CR38","doi-asserted-by":"crossref","unstructured":"Deng, Z. et al. TGF-\u03b2 signaling in health, disease and therapeutics. Signal Transduct. Target Ther. (2024).","DOI":"10.1038\/s41392-024-01764-w"},{"key":"2820_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07311-3","volume":"15","author":"T Gao","year":"2024","unstructured":"Gao, T. et al. Ovarian cancer-derived TGF-\u03b21 induces CAAs via SMAD3\/TRIB3. Cell Death Dis. 15, 930 (2024).","journal-title":"Cell Death Dis."},{"key":"2820_CR40","unstructured":"Yang, Z. et al. Cancer-associated adipocytes in breast cancer: mechanisms and crosstalk. Front. Oncol. 14, (2024)."},{"key":"2820_CR41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13005-023-00355-4","volume":"19","author":"S Gholami","year":"2023","unstructured":"Gholami, S. et al. Immunoexpression of HIF targets (GLUT1, MCT4, CAIX\u2026). Head. Face Med 19, 8 (2023).","journal-title":"Head. Face Med"},{"key":"2820_CR42","first-page":"391","volume":"8","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Targeting the lactic-acid metabolic pathway for antitumor therapy. Mol. Ther. Oncolytics. 8, 391 (2023).","journal-title":"Mol. Ther. Oncolytics."},{"key":"2820_CR43","doi-asserted-by":"crossref","unstructured":"Griffin, M. J. & Ryu, S. Immunometabolic role of NF-\u03baB in adipocytes. Int. J. Mol. Sci. 23, (2022).","DOI":"10.20900\/immunometab20220003"},{"key":"2820_CR44","first-page":"1139152","volume":"14","author":"S Guria","year":"2023","unstructured":"Guria, S. et al. Adipose tissue macrophages and their role in obesity. Front. Immunol. 14, 1139152 (2023).","journal-title":"Front. Immunol."},{"key":"2820_CR45","doi-asserted-by":"crossref","unstructured":"Wu, Q. et al. Immunoregulation in cancer-associated cachexia. J. Adv. Res. 58, 45\u201362 (2024).","DOI":"10.1016\/j.jare.2023.04.018"},{"key":"2820_CR46","doi-asserted-by":"crossref","unstructured":"Dong, D. L. et al. YAP and ECM stiffness: key drivers of adipocyte plasticity. Cells 13, 1905 (2024).","DOI":"10.3390\/cells13221905"},{"key":"2820_CR47","doi-asserted-by":"crossref","unstructured":"Luo, J. et al. New insights into the ambivalent role of YAP\/TAZ in human cancers. J. Exp Clin Cancer Res 42, 130 (2023).","DOI":"10.1186\/s13046-023-02704-2"},{"key":"2820_CR48","doi-asserted-by":"crossref","unstructured":"Shen, H. et al. Hippo pathway links adipocyte plasticity to adipose fibrosis. Nat. Commun. 13, 6030 (2022).","DOI":"10.1038\/s41467-022-33800-0"},{"key":"2820_CR49","unstructured":"Guo, B. et al. Runx1 activates transformation of adipocytes into CAAs and promotes breast cancer invasion. Biochem. Biophys. Res. Commun. (2025)."},{"key":"2820_CR50","unstructured":"Seo, S. H. et al. C\/EBP\u03b2 regulates HIF-1\u03b1-driven invasion under hypoxia. Antioxidants. 13 (2024)."},{"key":"2820_CR51","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.3390\/cancers15143580","volume":"15","author":"YC Lin","year":"2023","unstructured":"Lin, Y. C. et al. Adipocytes in PDAC: exosomes\/cytokines trigger lipolysis. Cancers 15, 3580 (2023).","journal-title":"Cancers"},{"key":"2820_CR52","unstructured":"Yu, Y. C. et al. KRAS-driven inflammatory cytokines shape the PDAC tumor microenvironment. Front. Oncol. 12, (2022)."},{"key":"2820_CR53","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12967-023-04256-7","volume":"21","author":"SQ Liu","year":"2023","unstructured":"Liu, S. Q. et al. Single-cell analysis of white adipose tissue reveals the tumor-promoting adipocyte subtypes. J. Transl. Med. 21, 470 (2023).","journal-title":"J. Transl. Med."},{"key":"2820_CR54","unstructured":"Zhao, G. et al. Single-cell RNA-seq reveals lipid-metabolic rewiring in obese vs nonobese breast tumors. Oncogene (2024)."},{"key":"2820_CR55","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347 (2021).","journal-title":"Nat. Genet."},{"key":"2820_CR56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.15407\/exp-oncology.2023.01.088","volume":"45","author":"L Bubnovskaya","year":"2023","unstructured":"Bubnovskaya, L., Ganusevich, I., Merentsev, S. & Osinsky, D. Cancer-associated adipocytes and prognostic value of preoperative neutrophil-lymphocyte ratio in gastric cancer. Exp. Oncol. 45, 88\u201398 (2023).","journal-title":"Exp. Oncol."},{"key":"2820_CR57","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1039\/D0NH00588F","volume":"6","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Tumor-targeted gene therapy with lipid nanoparticles inhibits tumor-associated adipocytes and remodels the immunosuppressive tumor microenvironment in triple-negative breast cancer. Nanoscale Horiz. 6, 319\u2013329 (2021).","journal-title":"Nanoscale Horiz."},{"key":"2820_CR58","doi-asserted-by":"crossref","unstructured":"Wolf, M. et al. Histologic characterization of tumor-adjacent mammary adipose tissue in normal-weight and overweight\/obese patients with triple-negative breast cancer. Cancers. 16, (2024).","DOI":"10.3390\/cancers16203515"},{"key":"2820_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07311-3","volume":"15","author":"T Gao","year":"2024","unstructured":"Gao, T. et al. Ovarian cancer-derived TGF-\u03b21 induces cancer-associated adipocytes formation by activating SMAD3\/TRIB3 pathway to establish premetastatic niche. Cell Death Dis. 15, 930 (2024).","journal-title":"Cell Death Dis."},{"key":"2820_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101943","volume":"84","author":"X Zeng","year":"2024","unstructured":"Zeng, X. et al. M2 macrophage-derived TGF-\u03b2 induces age-associated loss of adipogenesis through progenitor cell senescence. Mol. Metab. 84, 101943 (2024).","journal-title":"Mol. Metab."},{"key":"2820_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112759","volume":"140","author":"N Luo","year":"2024","unstructured":"Luo, N. et al. Hesperidin PLGA nanoparticles potentiate the efficacy of aPD-1 in treating triple negative breast cancer by regulating CCL2 and ADPN expression in cancer-associated adipocytes. Int. Immunopharmacol. 140, 112759 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"2820_CR62","doi-asserted-by":"publisher","first-page":"362244","DOI":"10.3389\/fonc.2024.1362244","volume":"14","author":"JB Permuth","year":"2024","unstructured":"Permuth, J. B. et al. Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-na\u00efve patients with pancreatic ductal adenocarcinoma. Front. Oncol. 14, 362244 (2024).","journal-title":"Front. Oncol."},{"key":"2820_CR63","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","volume":"186","author":"M Ferrer","year":"2023","unstructured":"Ferrer, M. et al. Cachexia: A systemic consequence of progressive, unresolved disease. Cell 186, 1824\u20131845 (2023).","journal-title":"Cell"},{"key":"2820_CR64","doi-asserted-by":"crossref","unstructured":"Mariean, C. R., Tiuc\u0103, O. M., Mariean, A. & Cotoi, O. S. Cancer Cachexia: New Insights and Future Directions. Cancers. 15, 5590 (2023).","DOI":"10.3390\/cancers15235590"},{"key":"2820_CR65","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","volume":"42","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia. Cancer Cell 42, 885\u2013903.e884 (2024).","journal-title":"Cancer Cell"},{"key":"2820_CR66","doi-asserted-by":"crossref","unstructured":"Poulia, K. A. et al. Pancreatic cancer and cachexia-metabolic mechanisms and novel insights. Nutrients. 12 (2020).","DOI":"10.3390\/nu12061543"},{"key":"2820_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.841758","volume":"12","author":"AY Gandhi","year":"2022","unstructured":"Gandhi, A. Y. et al. Cytokine-mediated STAT3 transcription supports ATGL\/CGI-58-dependent adipocyte lipolysis in cancer cachexia. Front. Oncol. 12, 841758 (2022).","journal-title":"Front. Oncol."},{"key":"2820_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116729","volume":"479","author":"X Pan","year":"2023","unstructured":"Pan, X. et al. Carnosol analog WK-63 alleviated cancer cachexia by inhibiting NF-\u03baB and activating AKT pathways in muscle while inhibiting NF-\u03baB and AMPK pathways in adipocyte. Toxicol. Appl. Pharm. 479, 116729 (2023).","journal-title":"Toxicol. Appl. Pharm."},{"key":"2820_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110901","volume":"112","author":"H Xiong","year":"2023","unstructured":"Xiong, H. et al. Exosomal EIF5A derived from Lewis lung carcinoma induced adipocyte wasting in cancer cachexia. Cell Signal 112, 110901 (2023).","journal-title":"Cell Signal"},{"key":"2820_CR70","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12929-024-01051-4","volume":"31","author":"CN Lin","year":"2024","unstructured":"Lin, C. N. et al. Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer. J. Biomed. Sci. 31, 62 (2024).","journal-title":"J. Biomed. Sci."},{"key":"2820_CR71","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1373\/clinchem.2007.100156","volume":"54","author":"S de Ferranti","year":"2008","unstructured":"de Ferranti, S. & Mozaffarian, D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin. Chem. 54, 945\u2013955 (2008).","journal-title":"Clin. Chem."},{"key":"2820_CR72","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1210\/en.2004-0478","volume":"145","author":"I Kharroubi","year":"2004","unstructured":"Kharroubi, I. et al. Free fatty acids and cytokines induce pancreatic beta-apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145, 5087\u20135096 (2004).","journal-title":"Endocrinology"},{"key":"2820_CR73","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1016\/j.orcp.2013.05.004","volume":"7","author":"M Matsuda","year":"2013","unstructured":"Matsuda, M. & Shimomura, I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes. Res. Clin. Pr. 7, e330\u2013e341 (2013).","journal-title":"Obes. Res. Clin. Pr."},{"key":"2820_CR74","first-page":"144","volume":"7","author":"KA Meyer","year":"2016","unstructured":"Meyer, K. A. et al. Adipocytes promote pancreatic cancer cell proliferation via glutamine transfer. Biochem. Biophys. Rep. 7, 144\u2013149 (2016).","journal-title":"Biochem. Biophys. Rep."},{"key":"2820_CR75","doi-asserted-by":"publisher","first-page":"20223","DOI":"10.18632\/oncotarget.7936","volume":"7","author":"E Zoico","year":"2016","unstructured":"Zoico, E. et al. Adipocytes WNT5a mediated dedifferentiation: a possible target in pancreatic cancer microenvironment. Oncotarget 7, 20223\u201320235 (2016).","journal-title":"Oncotarget"},{"key":"2820_CR76","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1126\/science.1198973","volume":"333","author":"SK Das","year":"2011","unstructured":"Das, S. K. et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 333, 233\u2013238 (2011).","journal-title":"Science"},{"key":"2820_CR77","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/cbdd.13029","volume":"90","author":"J Jin","year":"2017","unstructured":"Jin, J. et al. Design and synthesis of Atglistatin derivatives as adipose triglyceride lipase inhibitors. Chem. Biol. Drug Des. 90, 1122\u20131133 (2017).","journal-title":"Chem. Biol. Drug Des."},{"key":"2820_CR78","doi-asserted-by":"publisher","first-page":"886","DOI":"10.4161\/15384047.2014.987075","volume":"16","author":"KL Kliewer","year":"2015","unstructured":"Kliewer, K. L. et al. Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice. Cancer Biol. Ther. 16, 886\u2013897 (2015).","journal-title":"Cancer Biol. Ther."},{"key":"2820_CR79","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1136\/gutjnl-2011-300821","volume":"61","author":"PJ Grippo","year":"2012","unstructured":"Grippo, P. J. et al. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Gut 61, 1454\u20131464 (2012).","journal-title":"Gut"},{"key":"2820_CR80","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/gutjnl-2014-308350","volume":"65","author":"G Sagar","year":"2016","unstructured":"Sagar, G. et al. Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Gut 65, 1165\u20131174 (2016).","journal-title":"Gut"},{"key":"2820_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04987-y","volume":"9","author":"KM Gharpure","year":"2018","unstructured":"Gharpure, K. M. et al. FABP4 as a key determinant of metastatic potential of ovarian cancer. Nat. Commun. 9, 2923 (2018).","journal-title":"Nat. Commun."},{"key":"2820_CR82","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-19-1999","volume":"80","author":"A Mukherjee","year":"2020","unstructured":"Mukherjee, A. et al. Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance. Cancer Res. 80, 1748\u20131761 (2020).","journal-title":"Cancer Res."},{"key":"2820_CR83","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman, K. M. et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17, 1498\u20131503 (2011).","journal-title":"Nat. Med."},{"key":"2820_CR84","doi-asserted-by":"crossref","unstructured":"Takakura, T., Shimizu, T. & Yamamoto, N. Antibody\u2012drug conjugates in solid tumors; new strategy for cancer therapy. Jpn. J. Clin. Oncol. (2024).","DOI":"10.1093\/jjco\/hyae054"},{"key":"2820_CR85","doi-asserted-by":"crossref","unstructured":"Dzierlega, K. et al. Activin A-expressing polymorphonuclear myeloid-derived suppressor cells infiltrate skeletal and cardiac muscle and promote cancer cachexia. J. Immunol. (2023).","DOI":"10.4049\/jimmunol.2200064"},{"key":"2820_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101612","volume":"66","author":"M Lemecha","year":"2022","unstructured":"Lemecha, M. et al. Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia. Mol. Metab. 66, 101612 (2022).","journal-title":"Mol. Metab."},{"key":"2820_CR87","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3390\/ijms24021697","volume":"24","author":"A Fosch","year":"2023","unstructured":"Fosch, A. et al. Central regulation of brown fat thermogenesis in response to saturated or unsaturated long-chain fatty acids. Int. J. Mol. Sci. 24, 1697 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2820_CR88","doi-asserted-by":"crossref","unstructured":"Luan, Y., You, M., Thompson, T. & Kim, S. Y. Activin A plays a critical role in adipose tissue wasting in the progression of cancer cachexia. J. Endocr. Soc. (2021).","DOI":"10.1210\/jendso\/bvab048.078"},{"key":"2820_CR89","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1002\/1878-0261.13074","volume":"15","author":"ES Villodre","year":"2021","unstructured":"Villodre, E. S. et al. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Mol. Oncol. 15, 2752\u20132765 (2021).","journal-title":"Mol. Oncol."},{"key":"2820_CR90","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13045-023-01429-1","volume":"16","author":"D Wang","year":"2023","unstructured":"Wang, D. et al. LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia. J. Hematol. Oncol. 16, 30 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"2820_CR91","doi-asserted-by":"publisher","first-page":"1147676","DOI":"10.3389\/fcell.2023.1147676","volume":"11","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z., Zhang, H., Liao, X. & Tsai, H.-I. KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression. Front. Cell Dev. Biol. 11, 1147676 (2023).","journal-title":"Front. Cell Dev. Biol."},{"key":"2820_CR92","doi-asserted-by":"crossref","unstructured":"Miki, Y. et al. ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers. J. Endocr. Soc. (2022).","DOI":"10.1210\/jendso\/bvac150.1801"},{"key":"2820_CR93","doi-asserted-by":"crossref","unstructured":"Shen, X., Niu, N. & Xue, J. Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma. J. Transl. Intern. Med., 11, 322\u2013329 (2023).","DOI":"10.2478\/jtim-2022-0022"},{"key":"2820_CR94","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.18632\/oncotarget.1322","volume":"4","author":"G Schneider","year":"2013","unstructured":"Schneider, G. & Saur, D. Quo vadis, Kras?. Oncotarget 4, 1336\u20131337 (2013).","journal-title":"Oncotarget"},{"key":"2820_CR95","doi-asserted-by":"crossref","unstructured":"Riccardi, D. M. D. R. et al. Plasma lipid profile and systemic inflammation in patients with cancer cachexia. Front. Nutr. 7, (2020).","DOI":"10.3389\/fnut.2020.00004"},{"key":"2820_CR96","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2174\/1389557523666221226095931","volume":"23","author":"A Althaiban","year":"2023","unstructured":"Althaiban, A., Thyagarajan, A. & Sahu, R. P. KRAS pathway-based therapeutic approaches in pancreatic cancer. Mini Rev. Med. Chem. 23, 953\u2013961 (2023).","journal-title":"Mini Rev. Med. Chem."},{"key":"2820_CR97","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fonc.2020.00298","volume":"10","author":"GP Marceca","year":"2020","unstructured":"Marceca, G. P., Londhe, P. & Calore, F. Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options. Front. Oncol. 10, 298 (2020).","journal-title":"Front. Oncol."},{"key":"2820_CR98","doi-asserted-by":"publisher","first-page":"597675","DOI":"10.3389\/fphys.2020.597675","volume":"11","author":"JM Webster","year":"2020","unstructured":"Webster, J. M., Kempen, L. J. A. P., Hardy, R. S. & Langen, R. C. J. Inflammation and skeletal muscle wasting during cachexia. Front. Physiol. 11, 597675 (2020).","journal-title":"Front. Physiol."},{"key":"2820_CR99","first-page":"8066","volume":"14","author":"M Morimoto","year":"2017","unstructured":"Morimoto, M., Aikawa, K., Hara, T. & Yamaoka, M. Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models. Oncol. Lett. 14, 8066\u20138071 (2017).","journal-title":"Oncol. Lett."},{"key":"2820_CR100","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/fcp.12931","volume":"37","author":"S Dave","year":"2023","unstructured":"Dave, S. & Patel, B. M. Deliberation on debilitating condition of cancer cachexia: Skeletal muscle wasting. Fundam. Clin. Pharmacol. 37, 1079\u20131091 (2023).","journal-title":"Fundam. Clin. Pharmacol."},{"key":"2820_CR101","unstructured":"Miyazaki, M. in Physical Therapy and Research in Patients with Cancer (eds Morishita, S., Inoue, J. & Nakano, J.) 253\u2013274 (Springer Nature Singapore, 2022)."},{"key":"2820_CR102","doi-asserted-by":"publisher","first-page":"601329","DOI":"10.3389\/fnut.2020.601329","volume":"7","author":"WR van de Worp","year":"2020","unstructured":"van de Worp, W. R. et al. Nutritional interventions in cancer cachexia: evidence and perspectives from experimental models. Front. Nutr. 7, 601329 (2020).","journal-title":"Front. Nutr."},{"key":"2820_CR103","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.3390\/cells9122536","volume":"9","author":"G Aquila","year":"2020","unstructured":"Aquila, G. et al. Nutraceuticals and exercise against muscle wasting during cancer cachexia. Cells 9, 2536 (2020).","journal-title":"Cells"},{"key":"2820_CR104","unstructured":"Tian, J. Advances in understanding cancer-associated neurogenesis and its implications on the neuroimmune axis in cancer. Pharmacol. Ther. (2022)."},{"key":"2820_CR105","doi-asserted-by":"crossref","unstructured":"Yamamoto, K. et al. Targeting the metabolic rewiring in pancreatic cancer and its tumor microenvironment. Cancers (2022).","DOI":"10.3390\/cancers14184351"},{"key":"2820_CR106","doi-asserted-by":"crossref","unstructured":"Zuzcak, M. & Trnka, J. Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review). Int. J. Oncol. (2022).","DOI":"10.3892\/ijo.2022.5383"},{"key":"2820_CR107","doi-asserted-by":"crossref","unstructured":"Yin, X. et al. Orchestrating intratumoral DC-T-cell immunity for enhanced tumor control via radiotherapy-activated TLR7\/8 prodrugs in mice. Nat. Commun. (2025).","DOI":"10.1038\/s41467-025-60769-3"},{"key":"2820_CR108","doi-asserted-by":"crossref","unstructured":"Hankir, M. K., Hoffmann, A. & Seyfried, F. Starving cancer into submission by activating BAT. Cell Metab. (2022).","DOI":"10.1016\/j.cmet.2022.09.009"},{"key":"2820_CR109","doi-asserted-by":"crossref","unstructured":"Chen, H. et al. Deciphering the tumor cell-infiltrating landscapes reveal microenvironment subtypes and therapeutic potentials for nonsquamous NSCLC. JCI Insight (2022).","DOI":"10.2139\/ssrn.3875379"},{"key":"2820_CR110","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer. Semin. Cancer Biol. (2022).","DOI":"10.1016\/j.semcancer.2022.02.010"},{"key":"2820_CR111","doi-asserted-by":"crossref","unstructured":"Bandyopadhayaya, S., Ford, B. M. & Mandal, C. C. Cold-hearted: a case for cold stress in cancer risk. J. Therm. Biol. (2020).","DOI":"10.1016\/j.jtherbio.2020.102608"},{"key":"2820_CR112","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/jcsm.12918","volume":"13","author":"LJ Anderson","year":"2022","unstructured":"Anderson, L. J. et al. Whole-body and adipose tissue metabolic phenotype in cancer patients. J. Cachexia Sarcopenia Muscle 13, 1124\u20131133 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2820_CR113","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/j.clnu.2022.09.016","volume":"41","author":"E Cheng","year":"2022","unstructured":"Cheng, E. et al. Adipose tissue radiodensity and mortality among patients with nonmetastatic breast cancer. Clin. Nutr. 41, 2607\u20132613 (2022).","journal-title":"Clin. Nutr."},{"key":"2820_CR114","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1515\/jbcpp-2024-0057","volume":"35","author":"E Di Zazzo","year":"2024","unstructured":"Di Zazzo, E., Barone, B. & Crocetto, F. Adiponcosis interplay: adipose tissue, microenvironment and prostate cancer. J. Basic Clin. Physiol. Pharm. 35, 101\u2013103 (2024).","journal-title":"J. Basic Clin. Physiol. Pharm."},{"key":"2820_CR115","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/jcm2030136","volume":"2","author":"M Osisami","year":"2013","unstructured":"Osisami, M. & Keller, E. T. Mechanisms of metastatic tumor dormancy. J. Clin. Med. 2, 136\u2013150 (2013).","journal-title":"J. Clin. Med."},{"key":"2820_CR116","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10555-020-09934-2","volume":"40","author":"J-F Dumas","year":"2021","unstructured":"Dumas, J.-F. & Brisson, L. Interaction between adipose tissue and cancer cells: role for cancer progression. Cancer Metastasis Rev. 40, 31\u201346 (2021).","journal-title":"Cancer Metastasis Rev."},{"key":"2820_CR117","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.plipres.2017.11.002","volume":"69","author":"J Choi","year":"2018","unstructured":"Choi, J., Cha, Y. J. & Koo, J. S. Adipocyte biology in breast cancer: from silent bystander to active facilitator. Prog. Lipid Res. 69, 11\u201320 (2018).","journal-title":"Prog. Lipid Res."},{"key":"2820_CR118","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","volume":"127","author":"N Jain","year":"2016","unstructured":"Jain, N. et al. Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype. Blood 127, 1863\u20131869 (2016).","journal-title":"Blood"},{"key":"2820_CR119","first-page":"3019","volume":"141","author":"SJ Si Lim","year":"2023","unstructured":"Si Lim, S. J., Ford, J. B. & Hermiston, M. L. How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults. Blood 141, 3019\u20133030 (2023).","journal-title":"Blood"},{"key":"2820_CR120","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205854","volume":"10","author":"R Jia","year":"2023","unstructured":"Jia, R. et al. DEX-induced SREBF1 promotes BMSCs differentiation into adipocytes to attract and protect residual T-cell acute lymphoblastic leukemia cells after chemotherapy. Adv. Sci. 10, 2205854 (2023).","journal-title":"Adv. Sci."},{"key":"2820_CR121","doi-asserted-by":"crossref","unstructured":"Mohd Ali, N. et al. Adipose MSCs suppress MCF7 and MDA-MB-231 breast cancer metastasis and EMT pathways leading to dormancy via exosomal-mirnas following co-culture interaction. Pharmaceuticals 14, (2020).","DOI":"10.3390\/ph14010008"},{"key":"2820_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03449-4","volume":"24","author":"S P\u00e9rez-D\u00edaz","year":"2024","unstructured":"P\u00e9rez-D\u00edaz, S. et al. The potential role of collagen type VII in breast cancer proliferation. Cancer Cell Int. 24, 254 (2024).","journal-title":"Cancer Cell Int."},{"key":"2820_CR123","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.3390\/cancers14163908","volume":"14","author":"A Ritter","year":"2022","unstructured":"Ritter, A. et al. Adipose tissue-derived mesenchymal stromal\/stem cells, obesity and the tumor microenvironment of breast cancer. Cancers 14, 3908 (2022).","journal-title":"Cancers"},{"key":"2820_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151645","volume":"758","author":"Y Kurihara","year":"2025","unstructured":"Kurihara, Y. et al. Mycobacterium abscessus resides within lipid droplets and acquires a dormancy-like phenotype in adipocytes. Biochem. Biophys. Res. Commun. 758, 151645 (2025).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2820_CR125","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bjps.2023.05.006","volume":"83","author":"M Nystr\u00f6m","year":"2023","unstructured":"Nystr\u00f6m, M. et al. Interaction of adipose-derived stem cells with active and dormant breast cancer cells. J. Plast. Reconstr. Aesthet. Surg. 83, 69\u201376 (2023).","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"2820_CR126","doi-asserted-by":"crossref","unstructured":"Ma, X., Yang, S. & Li, D. New Insights Into Adipokines and the Tumor Microenvironment in Breast Cancer. Cancer Control, 32, 10732748251347917 (2025).","DOI":"10.1177\/10732748251347917"},{"key":"2820_CR127","doi-asserted-by":"crossref","unstructured":"Redoute-Timonnier, C. & Auguste, P. Implication of the extracellular matrix in metastatic tumor cell dormancy. Cancers, 16, 4076 (2024).","DOI":"10.3390\/cancers16234076"},{"key":"2820_CR128","doi-asserted-by":"crossref","unstructured":"El Alaa, R. S. A. et al. Adipose-derived stromal cells and cancer-associated fibroblasts: interactions and implications in tumor progression. Int. J. Mol. Sci. 25, 11558 (2024).","DOI":"10.3390\/ijms252111558"},{"key":"2820_CR129","doi-asserted-by":"crossref","unstructured":"Deligne, C. et al. Matrix-targeting immunotherapy controls tumor growth and spread by switching macrophage phenotype. Cancer Immunol. Res. 8, 368\u2013382 (2020).","DOI":"10.1158\/2326-6066.CIR-19-0276"},{"key":"2820_CR130","doi-asserted-by":"crossref","unstructured":"Popova, N. V. & J\u00fccker, M. The functional role of extracellular matrix proteins in cancer. Cancers 14, 238 (2022).","DOI":"10.3390\/cancers14010238"},{"key":"2820_CR131","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. The role of tenascin-C in tumor microenvironments and its potential as a therapeutic target. Front. Cell Dev. Biol. 13, 1554312 (2025).","DOI":"10.3389\/fcell.2025.1554312"},{"key":"2820_CR132","doi-asserted-by":"crossref","unstructured":"Silvers, C. R. et al. Tenascin-C expression in the lymph node pre-metastatic niche in muscle-invasive bladder cancer. Br. J. Cancer 125, 1399\u20131407 (2021).","DOI":"10.1038\/s41416-021-01554-z"},{"key":"2820_CR133","doi-asserted-by":"crossref","unstructured":"Iacono, M. L. et al. Targeting of the peritumoral adipose tissue microenvironment as an innovative antitumor therapeutic strategy. Biomolecules 12, 702 (2022).","DOI":"10.3390\/biom12050702"},{"key":"2820_CR134","doi-asserted-by":"crossref","unstructured":"Li, Z. et al. Omentum provides a special cell microenvironment for ovarian cancer. Cancer Rep. (Hoboken) 6, e1858 (2023).","DOI":"10.1002\/cnr2.1858"},{"key":"2820_CR135","doi-asserted-by":"crossref","unstructured":"Duarte Mendes, A. et al. Adipocyte microenvironment in ovarian cancer: a critical contributor? Int. J. Mol. Sci. 24, 16589 (2023).","DOI":"10.3390\/ijms242316589"},{"key":"2820_CR136","doi-asserted-by":"crossref","unstructured":"Yoon, H. & Lee, S. Fatty acid metabolism in ovarian cancer: therapeutic implications. Int. J. Mol. Sci. 23, 2170 (2022).","DOI":"10.3390\/ijms23042170"},{"key":"2820_CR137","doi-asserted-by":"crossref","unstructured":"Mukherjee, A. et al. Adipocytes reprogram cancer cell metabolism by diverting glucose towards glycerol-3-phosphate thereby promoting metastasis. Nat. Metab. 5, 1563\u20131577 (2023).","DOI":"10.1038\/s42255-023-00879-8"},{"key":"2820_CR138","doi-asserted-by":"crossref","unstructured":"Lin, C. N. et al. Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer. J. Biomed. Sci. 31, 62 (2024).","DOI":"10.1186\/s12929-024-01051-4"},{"key":"2820_CR139","unstructured":"Dong, Q. Premetastatic niche formation in different organs. Front. Cell Dev. Biol. (2021)."},{"key":"2820_CR140","unstructured":"Lee, S. A. Biophysical interplay between ECM and cancer. Front. Oncol. (2024)."},{"key":"2820_CR141","doi-asserted-by":"crossref","unstructured":"Patras, L. Immune determinants of the premetastatic niche. Cancer Cell (2023).","DOI":"10.1016\/j.ccell.2023.02.018"},{"key":"2820_CR142","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang, M. & Zhang, B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp. Hematol. Oncol. 14, 54 (2025).","journal-title":"Exp. Hematol. Oncol."},{"key":"2820_CR143","doi-asserted-by":"publisher","first-page":"751239","DOI":"10.3389\/fphys.2021.751239","volume":"12","author":"CK Brock","year":"2021","unstructured":"Brock, C. K. et al. A role for adipocytes and adipose stem cells in the breast tumor microenvironment and regenerative medicine. Front. Physiol. 12, 751239 (2021).","journal-title":"Front. Physiol."},{"key":"2820_CR144","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-022-01297-1","volume":"15","author":"Y Xie","year":"2022","unstructured":"Xie, Y. et al. Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis. J. Hematol. Oncol. 15, 72 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"2820_CR145","volume":"9","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Adipocyte-derived exosomal MTTP suppresses ferroptosis and promotes chemoresistance in colorectal cancer. Adv. Sci. (Weinh.) 9, 2203357 (2022).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"2820_CR146","doi-asserted-by":"publisher","first-page":"992","DOI":"10.4149\/neo_2020_191017N1050","volume":"67","author":"HM Kim","year":"2020","unstructured":"Kim, H. M., Lee, Y. K., Kim, E. S. & Koo, J. S. Energy transfer from adipocytes to cancer cells in breast cancer. Neoplasma 67, 992\u20131001 (2020).","journal-title":"Neoplasma"},{"key":"2820_CR147","doi-asserted-by":"crossref","unstructured":"Micallef, P. et al. Adipose tissue-breast cancer crosstalk leads to increased tumor lipogenesis associated with enhanced tumor growth. Int. J. Mol. Sci. 22, (2021).","DOI":"10.3390\/ijms222111881"},{"key":"2820_CR148","doi-asserted-by":"crossref","unstructured":"Cai, Z. et al. Adipocytes promote pancreatic cancer migration and invasion through fatty acid metabolic reprogramming. Oncol. Rep. 50, (2023).","DOI":"10.3892\/or.2023.8578"},{"key":"2820_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101512","volume":"61","author":"S Lecoutre","year":"2022","unstructured":"Lecoutre, S. et al. Beta-hydroxybutyrate dampens adipose progenitors\u2019 profibrotic activation through canonical Tgf\u03b2 signaling and noncanonical ZFP36-dependent mechanisms. Mol. Metab. 61, 101512 (2022).","journal-title":"Mol. Metab."},{"key":"2820_CR150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13046-024-02981-5","volume":"43","author":"CN Lin","year":"2024","unstructured":"Lin, C. N., Li, W. & Wang, T. Adipocyte pyroptosis in omental metastases releases FFAs and fuels chemoresistance. J. Exp. Clin. Cancer Res. 43, 56 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2820_CR151","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3390\/cancers16061122","volume":"16","author":"E Solsona-Vilarrasa","year":"2024","unstructured":"Solsona-Vilarrasa, E., Fucho, R., Garc\u00eda-Ruiz, C. & Fern\u00e1ndez-Checa, J. C. Adipose tissue dysfunction and its role in cancer progression. Cancers 16, 1122 (2024).","journal-title":"Cancers"},{"key":"2820_CR152","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/cancers15030986","volume":"15","author":"KA Brown","year":"2023","unstructured":"Brown, K. A. Adipose tissue\u2013tumor crosstalk: metabolic drivers of metastasis. Cancers 15, 986 (2023).","journal-title":"Cancers"},{"key":"2820_CR153","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.3390\/cancers14163975","volume":"14","author":"O Habanjar","year":"2022","unstructured":"Habanjar, O., Diab-Assaf, M., Caldefie-Chezet, F. & Delort, L. Crosstalk between obesity and breast cancer: new insights on the role of adipokines. Cancers 14, 3975 (2022).","journal-title":"Cancers"},{"key":"2820_CR154","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.3390\/ijms24032102","volume":"24","author":"Y Li","year":"2023","unstructured":"Li, Y., Xu, Q. & Ma, L. Obesity-induced inflammation and its impact on cancer progression. Int. J. Mol. Sci. 24, 2102 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2820_CR155","first-page":"862153","volume":"13","author":"L Yao","year":"2022","unstructured":"Yao, L., Xu, J. & Chen, H. Systemic low-grade inflammation links obesity to cancer risk. Front. Immunol. 13, 862153 (2022).","journal-title":"Front. Immunol."},{"key":"2820_CR156","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.3390\/ijms25115658","volume":"25","author":"C Meier","year":"2024","unstructured":"Meier, C. & Lopez, J. NLRP3-driven systemic inflammation and tumor promotion. Int. J. Mol. Sci. 25, 2678 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"2820_CR157","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3390\/cancers16101942","volume":"16","author":"S Ramachandran","year":"2024","unstructured":"Ramachandran, S. & Natarajan, R. Inflammasome activation in metabolic disease and cancer. Cancers 16, 1942 (2024).","journal-title":"Cancers"},{"key":"2820_CR158","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.3390\/cancers16142558","volume":"16","author":"Y Suzuki","year":"2024","unstructured":"Suzuki, Y. & Watanabe, K. Circulating adipokines and recurrence risk in cancer patients. Cancers 16, 2450 (2024).","journal-title":"Cancers"},{"key":"2820_CR159","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3390\/cancers15071987","volume":"15","author":"AD Mendes","year":"2023","unstructured":"Mendes, A. D. & Ribeiro, D. Adipocyte microenvironment in ovarian cancer. Cancers 15, 1987 (2023).","journal-title":"Cancers"},{"key":"2820_CR160","doi-asserted-by":"publisher","first-page":"11789","DOI":"10.3390\/ijms23042170","volume":"23","author":"H Yoon","year":"2022","unstructured":"Yoon, H. & Kim, D. Fatty acid metabolism in ovarian cancer\u2014link to metastasis and adipocyte coculture. Int. J. Mol. Sci. 23, 11789 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2820_CR161","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/cancers17020321","volume":"17","author":"S Ramu","year":"2025","unstructured":"Ramu, S. & Chandra, P. Adipose extracellular vesicles as systemic modulators of cancer. Cancers 17, 321 (2025).","journal-title":"Cancers"},{"key":"2820_CR162","first-page":"1150","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang, Y. & Zhang, L. Extracellular vesicles from adipose tissue in tumor progression. Front. Oncol. 14, 1150 (2024).","journal-title":"Front. Oncol."},{"key":"2820_CR163","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.3390\/cancers16142611","volume":"16","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. & Guo, J. Adipose-derived stem cell exosomes reprogram breast tumor behavior. Cancers 16, 2611 (2024).","journal-title":"Cancers"},{"key":"2820_CR164","first-page":"944160","volume":"13","author":"D Aguilar-Cazares","year":"2022","unstructured":"Aguilar-Cazares, D. & Chavez-Dominguez, R. Adipose tissue inflammation and immune suppression in cancer. Front. Immunol. 13, 944160 (2022).","journal-title":"Front. Immunol."},{"key":"2820_CR165","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.3390\/ijms24044111","volume":"24","author":"A Guria","year":"2023","unstructured":"Guria, A. & Sarkar, S. Adipose tissue macrophage plasticity in cancer-associated inflammation. Int. J. Mol. Sci. 24, 4111 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2820_CR166","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1159411","volume":"14","author":"M Deng","year":"2023","unstructured":"Deng, M. et al. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia. Front. Immunol. 14, 1159411 (2023).","journal-title":"Front. Immunol."},{"key":"2820_CR167","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.2147\/JIR.S504390","volume":"18","author":"J Hu","year":"2025","unstructured":"Hu, J. et al. Identification and evaluation of lipocalin-2 in sepsis-associated encephalopathy via machine learning approaches. J. Inflamm. Res. 18, 3843\u20133858 (2025).","journal-title":"J. Inflamm. Res."},{"key":"2820_CR168","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1016\/j.apsb.2024.07.021","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nanobased drug delivery systems for cancer therapy. Acta Pharm. Sin. B 14, 4717\u20134737 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"2820_CR169","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tips.2024.04.007","volume":"45","author":"AR Terry","year":"2024","unstructured":"Terry, A. R. & Hay, N. Emerging targets in lipid metabolism for cancer therapy. Trends Pharm. Sci. 45, 537\u2013551 (2024).","journal-title":"Trends Pharm. Sci."},{"key":"2820_CR170","doi-asserted-by":"publisher","first-page":"1079076","DOI":"10.3389\/fcell.2022.1079076","volume":"10","author":"SL Guerrero-Rodr\u00edguez","year":"2022","unstructured":"Guerrero-Rodr\u00edguez, S. L., Mata-Cruz, C., P\u00e9rez-Tapia, S. M. & Velasco-Vel\u00e1zquez, M. A. Role of CD36 in cancer progression, stemness, and targeting. Front. Cell Dev. Biol. 10, 1079076 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"2820_CR171","unstructured":"Tzeng, S.-F., et al. Clinical development of a neutralizing CD36 antibody (PLT-012) reverses lipid-fueled immune suppression and shows activity in advanced cancers. Cancer Discov. (2025)."},{"key":"2820_CR172","first-page":"2070","volume":"18","author":"J Geppert","year":"2024","unstructured":"Geppert, J. & Rohm, M. Cancer cachexia: biomarkers and the influence of age. Mol. Oncol. 18, 2070\u20132086 (2024).","journal-title":"Mol. Oncol."},{"key":"2820_CR173","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","volume":"26","author":"R Suriben","year":"2020","unstructured":"Suriben, R. et al. Antibody-mediated inhibition of GDF15\u2013GFRAL activity reverses cancer cachexia in mice. Nat. Med. 26, 1264\u20131270 (2020).","journal-title":"Nat. Med."},{"key":"2820_CR174","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cpt.2023.03.002","volume":"1","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Association between high body mass index and prognosis of patients with early-stage breast cancer: a systematic review and meta-analysis. Cancer Pathog. Ther. 1, 205\u2013215 (2023).","journal-title":"Cancer Pathog. Ther."},{"key":"2820_CR175","doi-asserted-by":"publisher","DOI":"10.1097\/IJ9.0000000000000077","volume":"4","author":"J Goedeke","year":"2019","unstructured":"Goedeke, J. & Muensterer, O. J. The role of obesity in cancer development. IJS Oncol. 4, e77 (2019).","journal-title":"IJS Oncol."},{"key":"2820_CR176","doi-asserted-by":"crossref","unstructured":"Bhattacharya, N., Maurya, S. K., Bhattacharya, A. & Senapati, S. in Obesity and Cancer (eds Kumar, S. & Gupta, S.) 1\u201312 (Springer Singapore, 2021).","DOI":"10.1007\/978-981-16-1846-8_1"},{"key":"2820_CR177","first-page":"1213","volume":"13","author":"MN Amin","year":"2019","unstructured":"Amin, M. N. et al. How the association between obesity and inflammation may lead to insulin resistance and cancer. Diab. Metab. Syndr. Clin. Res. Rev. 13, 1213\u20131224 (2019).","journal-title":"Diab. Metab. Syndr. Clin. Res. Rev."},{"key":"2820_CR178","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12929-022-00796-0","volume":"29","author":"JAF Assump\u00e7\u00e3o","year":"2022","unstructured":"Assump\u00e7\u00e3o, J. A. F. et al. The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy. J. Biomed. Sci. 29, 12 (2022).","journal-title":"J. Biomed. Sci."},{"key":"2820_CR179","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03114-z","volume":"21","author":"E Fontvieille","year":"2023","unstructured":"Fontvieille, E. et al. Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies. BMC Med. 21, 418 (2023).","journal-title":"BMC Med."},{"key":"2820_CR180","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41416-024-02906-1","volume":"132","author":"W Wang","year":"2025","unstructured":"Wang, W. et al. Normal weight obesity, circulating biomarkers and risk of breast cancer: a prospective cohort study and meta-analysis. Br. J. Cancer 132, 203\u2013211 (2025).","journal-title":"Br. J. Cancer"},{"key":"2820_CR181","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1210\/clinem\/dgac241","volume":"107","author":"SC Naaman","year":"2022","unstructured":"Naaman, S. C., Shen, S., Zeytinoglu, M. & Iyengar, N. M. Obesity and breast cancer risk: the oncogenic implications of metabolic dysregulation. J. Clin. Endocrinol. Metab. 107, 2154\u20132166 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2820_CR182","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1158\/1940-6207.CAPR-18-0207","volume":"12","author":"H Greenlee","year":"2019","unstructured":"Greenlee, H. et al. Obesity-associated breast inflammation among Hispanic\/Latina breast cancer patients. Cancer Prev. Res. (Philos.) 12, 21\u201330 (2019).","journal-title":"Cancer Prev. Res. (Philos.)"},{"key":"2820_CR183","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/jcsm.13415","volume":"15","author":"YZ Ge","year":"2024","unstructured":"Ge, Y. Z. et al. The age-related obesity paradigm: results from two large prospective cohort studies. J. Cachexia Sarcopenia Muscle 15, 442\u2013452 (2024).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2820_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2025.103859","volume":"35","author":"AQ Mohammed","year":"2025","unstructured":"Mohammed, A. Q. et al. Association of novel inflammatory and metabolic markers with mortality in individuals with overweight and obesity. Nutr. Metab. Cardiovasc. Dis. 35, 103859 (2025).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"2820_CR185","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.amepre.2017.04.025","volume":"53","author":"YC Yang","year":"2017","unstructured":"Yang, Y. C. et al. Young adult risk factors for cancer: obesity, inflammation, and sociobehavioral mechanisms. Am. J. Prev. Med. 53, S21\u2013s29 (2017).","journal-title":"Am. J. Prev. Med."},{"key":"2820_CR186","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.metabol.2019.01.007","volume":"94","author":"DT Dibaba","year":"2019","unstructured":"Dibaba, D. T. et al. Association between obesity and biomarkers of inflammation and metabolism with cancer mortality in a prospective cohort study. Metabolism 94, 69\u201376 (2019).","journal-title":"Metabolism"},{"key":"2820_CR187","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/mc.22842","volume":"57","author":"BZ Huang","year":"2018","unstructured":"Huang, B. Z. et al. Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk. Mol. Carcinog. 57, 1278\u20131288 (2018).","journal-title":"Mol. Carcinog."},{"key":"2820_CR188","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1002\/cam4.4713","volume":"11","author":"M Gholami","year":"2022","unstructured":"Gholami, M. et al. Association of miRNA targetome variants in LAMC1 and GNB3 genes with colorectal cancer and obesity. Cancer Med. 11, 3923\u20133938 (2022).","journal-title":"Cancer Med."},{"key":"2820_CR189","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3892\/mco.2024.2762","volume":"21","author":"R Jiang","year":"2024","unstructured":"Jiang, R. et al. Association between body mass index combined with high-sensitivity C-reactive protein and the risk of postmenopausal breast cancer: a prospective cohort study. Mol. Clin. Oncol. 21, 64 (2024).","journal-title":"Mol. Clin. Oncol."},{"key":"2820_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64428-3","volume":"14","author":"JB Holm","year":"2024","unstructured":"Holm, J. B. et al. Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups. Sci. Rep. 14, 14486 (2024).","journal-title":"Sci. Rep."},{"key":"2820_CR191","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00304-x","volume":"7","author":"MC Chang","year":"2021","unstructured":"Chang, M. C., Eslami, Z., Ennis, M. & Goodwin, P. J. Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis. NPJ Breast Cancer 7, 97 (2021).","journal-title":"NPJ Breast Cancer"},{"key":"2820_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11696-6","volume":"12","author":"CN Birts","year":"2022","unstructured":"Birts, C. N. et al. Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2\u2009+\u2009breast carcinoma. Sci. Rep. 12, 7802 (2022).","journal-title":"Sci. Rep."},{"key":"2820_CR193","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01308-4","volume":"22","author":"ML Maliniak","year":"2020","unstructured":"Maliniak, M. L. et al. Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer. Breast Cancer Res. 22, 65 (2020).","journal-title":"Breast Cancer Res."},{"key":"2820_CR194","doi-asserted-by":"publisher","first-page":"104991","DOI":"10.1016\/j.ebiom.2024.104991","volume":"100","author":"J Yarmolinsky","year":"2024","unstructured":"Yarmolinsky, J. et al. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. EBioMedicine 100, 104991 (2024).","journal-title":"EBioMedicine"},{"key":"2820_CR195","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10549-023-07169-7","volume":"204","author":"MC Zwager","year":"2024","unstructured":"Zwager, M. C. et al. Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1\/2 gene mutation carriers and breast cancer patients. Breast Cancer Res. Treat. 204, 27\u201337 (2024).","journal-title":"Breast Cancer Res. Treat."},{"key":"2820_CR196","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14399-0","volume":"12","author":"CN Birts","year":"2022","unstructured":"Birts, C. N., Davies, C. C. & Blaydes, J. P. Crown-like structures in breast adipose tissue are associated with trastuzumab resistance and poorer prognosis in HER2-positive breast cancer. Sci. Rep. 12, 10107 (2022).","journal-title":"Sci. Rep."},{"key":"2820_CR197","doi-asserted-by":"crossref","unstructured":"Wu, C., Dong, S., Huang, R. & Chen, X. Cancer-associated adipocytes and breast cancer: intertwining in the tumor microenvironment and challenges for cancer therapy. Cancers 15, 726 (2023).","DOI":"10.3390\/cancers15030726"},{"key":"2820_CR198","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.62347\/XZRI9189","volume":"14","author":"Q Cai","year":"2024","unstructured":"Cai, Q., Yang, J., Shen, H. & Xu, W. Cancer-associated adipocytes in the ovarian cancer microenvironment. Am. J. Cancer Res. 14, 3259\u20133279 (2024).","journal-title":"Am. J. Cancer Res."},{"key":"2820_CR199","doi-asserted-by":"crossref","unstructured":"Grigora\u0219, A. & Amalinei, C. Multi-faceted role of cancer-associated adipocytes in colorectal cancer. Biomedicines. 11, (2023).","DOI":"10.3390\/biomedicines11092401"},{"key":"2820_CR200","doi-asserted-by":"crossref","unstructured":"Na, H., Song, Y. & Lee, H. W. Emphasis on adipocyte transformation: anti-inflammatory agents to prevent the development of cancer-associated adipocytes. Cancers 15, 502 (2023).","DOI":"10.3390\/cancers15020502"},{"key":"2820_CR201","doi-asserted-by":"crossref","unstructured":"Sanhueza, S., Sim\u00f3n, L., Cifuentes, M. & Quest, A. F. G. The adipocyte-macrophage relationship in cancer: a potential target for antioxidant therapy. Antioxidants. 12, (2023).","DOI":"10.3390\/antiox12010126"},{"key":"2820_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35200","volume":"10","author":"Z Yang","year":"2024","unstructured":"Yang, Z. et al. Dissecting the emerging role of cancer-associated adipocyte-derived cytokines in remodeling breast cancer progression. Heliyon 10, e35200 (2024).","journal-title":"Heliyon"},{"key":"2820_CR203","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"H Huang","year":"2024","unstructured":"Huang, H. et al. Cellular succinate metabolism and signaling in inflammation. Signal Transduct. Target. Ther. 9, 78 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2820_CR204","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41392-023-01605-2","volume":"8","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Targeting the lactic acid metabolic pathway for antitumor therapy. Signal Transduct. Target. Ther. 8, 391 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2820_CR205","doi-asserted-by":"publisher","first-page":"1266973","DOI":"10.3389\/fcell.2023.1266973","volume":"11","author":"W Zhang","year":"2023","unstructured":"Zhang, W. & Lang, R. Succinate metabolism: a promising therapeutic target for inflammation, ischemia\/reperfusion injury and cancer. Front. Cell Dev. Biol. 11, 1266973 (2023).","journal-title":"Front. Cell Dev. Biol."},{"key":"2820_CR206","unstructured":"Ghosh, R. et al. Targeting HIF-1\u03b1 by natural and synthetic compounds. Biomedicines. 10, (2022)."},{"key":"2820_CR207","doi-asserted-by":"crossref","unstructured":"Griffin, M. J. & Ryu, S. On the immunometabolic role of NF-\u03baB in adipocytes. Int. J. Mol. Sci. 23, (2022).","DOI":"10.20900\/immunometab20220003"},{"key":"2820_CR208","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/21623945.2020.1760674","volume":"9","author":"K McKernan","year":"2020","unstructured":"McKernan, K. et al. Role of TLR4 in the induction of inflammatory changes in adipocytes and macrophages. Adipocyte 9, 212\u2013222 (2020).","journal-title":"Adipocyte"},{"key":"2820_CR209","first-page":"117800","volume":"254","author":"HX Dou","year":"2020","unstructured":"Dou, H. X. et al. Exogenous FABP4 induces p38\/HSL-mediated lipolysis and p38\/NF-\u03baB-mediated inflammation. Life Sci. 254, 117800 (2020).","journal-title":"Life Sci."},{"key":"2820_CR210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41420-023-01652-2","volume":"9","author":"C Jiang","year":"2023","unstructured":"Jiang, C. et al. Small extracellular vesicle-mediated metabolic reprogramming. Cell Death Discov. 9, 383 (2023).","journal-title":"Cell Death Discov."},{"key":"2820_CR211","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.3390\/ijms21218261","volume":"21","author":"M Leiva","year":"2020","unstructured":"Leiva, M. et al. Unraveling the role of p38 family members in adipose tissue. Int. J. Mol. Sci. 21, 8261 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2820_CR212","first-page":"1305939","volume":"14","author":"C Qin","year":"2024","unstructured":"Qin, C. et al. The systematic role of pancreatic cancer exosomes. Front. Oncol. 14, 1305939 (2024).","journal-title":"Front. Oncol."},{"key":"2820_CR213","unstructured":"Fontana, F. et al. The PI3K\/Akt pathway and glucose metabolism. Int. J. Mol. Sci. 25, (2024)."},{"key":"2820_CR214","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33349-y","volume":"13","author":"L Yang","year":"2022","unstructured":"Yang, L. CD36-mediated metabolic crosstalk between tumor and immune cells in liver cancer. Nat. Commun. 13, 5782 (2022).","journal-title":"Nat. Commun."},{"key":"2820_CR215","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14375-7","volume":"25","author":"A Jurj","year":"2025","unstructured":"Jurj, A., Paul, D. & Calin, G. A. Extracellular vesicles in cancer: from isolation and characterization to metastasis, drug resistance, and clinical applications. BMC Cancer 25, 1154 (2025).","journal-title":"BMC Cancer"},{"key":"2820_CR216","doi-asserted-by":"publisher","first-page":"371","DOI":"10.20517\/evcna.2024.36","volume":"5","author":"CC Ramos","year":"2024","unstructured":"Ramos, C. C. et al. Extracellular vesicles in tumor-adipose tissue crosstalk: key drivers and therapeutic targets in cancer cachexia. Extracell. Vesicles Circ. Nucl. Acids 5, 371\u2013396 (2024).","journal-title":"Extracell. Vesicles Circ. Nucl. Acids"},{"key":"2820_CR217","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s13105-024-01048-5","volume":"81","author":"G Neira","year":"2025","unstructured":"Neira, G. et al. Increased expression of IL-1\u03b2 in adipose tissue in obesity influences the development of colon cancer by promoting inflammation. J. Physiol. Biochem 81, 471\u2013482 (2025).","journal-title":"J. Physiol. Biochem"},{"key":"2820_CR218","doi-asserted-by":"crossref","unstructured":"Maliniak, M. L. et al. Crown-like structures in breast adipose tissue: early evidence and current issues in breast cancer. Cancers. 13, (2021).","DOI":"10.3390\/cancers13092222"},{"key":"2820_CR219","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/imr.13344","volume":"324","author":"TD Randall","year":"2024","unstructured":"Randall, T. D. & Meza-Perez, S. Immunity in adipose tissues: cutting through the fat. Immunol. Rev. 324, 4\u201310 (2024).","journal-title":"Immunol. Rev."},{"key":"2820_CR220","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109698","volume":"254","author":"T Liu","year":"2023","unstructured":"Liu, T. et al. ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1\u03b1 ubiquitination in sepsis. Clin. Immunol. 254, 109698 (2023).","journal-title":"Clin. Immunol."},{"key":"2820_CR221","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303075120","volume":"120","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. FAP expression in adipose tissue macrophages promotes obesity and metabolic inflammation. Proc. Natl. Acad. Sci. USA 120, e2303075120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2820_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112928","volume":"42","author":"NT Sprenkle","year":"2023","unstructured":"Sprenkle, N. T. et al. The miR-23-27-24 clusters drive lipid-associated macrophage proliferation in obese adipose tissue. Cell Rep. 42, 112928 (2023).","journal-title":"Cell Rep."},{"key":"2820_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111663","volume":"211","author":"SM Oussaada","year":"2024","unstructured":"Oussaada, S. M. et al. Tissue-specific inflammation and insulin sensitivity in subjects with obesity. Diab. Res Clin. Pr. 211, 111663 (2024).","journal-title":"Diab. Res Clin. Pr."},{"key":"2820_CR224","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1210\/jc.2014-2074","volume":"99","author":"G Tarantino","year":"2014","unstructured":"Tarantino, G. Gut microbiome, obesity-related comorbidities, and low-grade chronic inflammation. J. Clin. Endocrinol. Metab. 99, 2343\u20132346 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2820_CR225","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.cmet.2023.05.011","volume":"35","author":"X Lu","year":"2023","unstructured":"Lu, X. et al. UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders. Cell Metab. 35, 1390\u20131405.e1398 (2023).","journal-title":"Cell Metab."},{"key":"2820_CR226","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/SLA.0000000000005954","volume":"278","author":"R Wu","year":"2023","unstructured":"Wu, R. et al. Intratumoral tumor infiltrating lymphocytes (TILs) are associated with cell proliferation and better survival however, not always with chemotherapy response in breast cancer. Ann. Surg. 278, 587\u2013597 (2023).","journal-title":"Ann. Surg."},{"key":"2820_CR227","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.immuni.2022.11.013","volume":"56","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development. Immunity 56, 58\u201377.e11 (2023).","journal-title":"Immunity"},{"key":"2820_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113963","volume":"43","author":"X Liao","year":"2024","unstructured":"Liao, X. et al. Adipose stem cells control obesity-induced T-cell infiltration into adipose tissue. Cell Rep. 43, 113963 (2024).","journal-title":"Cell Rep."},{"key":"2820_CR229","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45724-y","volume":"15","author":"I Reinisch","year":"2024","unstructured":"Reinisch, I. et al. Adipocyte p53 coordinates the response to intermittent fasting by regulating adipose tissue immune cell landscape. Nat. Commun. 15, 1391 (2024).","journal-title":"Nat. Commun."},{"key":"2820_CR230","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/s41388-018-0592-6","volume":"38","author":"R Kolb","year":"2019","unstructured":"Kolb, R. et al. Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4. Oncogene 38, 2351\u20132363 (2019).","journal-title":"Oncogene"},{"key":"2820_CR231","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/2159-8290.CD-15-1177","volume":"6","author":"J Incio","year":"2016","unstructured":"Incio, J. et al. Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy. Cancer Discov. 6, 852\u2013869 (2016).","journal-title":"Cancer Discov."},{"key":"2820_CR232","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1002\/cncr.34356","volume":"128","author":"LA Moukarzel","year":"2022","unstructured":"Moukarzel, L. A. et al. Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancer. Cancer 128, 3297\u20133309 (2022).","journal-title":"Cancer"},{"key":"2820_CR233","doi-asserted-by":"crossref","unstructured":"Lee, J. H., Hyung, S., Lee, J. & Choi, S. H. Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study. J. Immunother. Cancer. 10, e005226 (2022).","DOI":"10.1136\/jitc-2022-005226"},{"key":"2820_CR234","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2217\/imt.15.12","volume":"7","author":"A Mirsoian","year":"2015","unstructured":"Mirsoian, A. & Murphy, W. J. Obesity and cancer immunotherapy toxicity. Immunotherapy 7, 319\u2013322 (2015).","journal-title":"Immunotherapy"},{"key":"2820_CR235","unstructured":"Pasupuleti, S. K. et al. Obesity-induced inflammation exacerbates clonal hematopoiesis. J. Clin. Invest. 133, (2023)."},{"key":"2820_CR236","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S002966511100320X","volume":"71","author":"SL Doyle","year":"2012","unstructured":"Doyle, S. L., Donohoe, C. L., Lysaght, J. & Reynolds, J. V. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc. Nutr. Soc. 71, 181\u2013189 (2012).","journal-title":"Proc. Nutr. Soc."},{"key":"2820_CR237","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/jnci\/djae134","volume":"116","author":"TK Lam","year":"2024","unstructured":"Lam, T. K. et al. Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers. J. Natl. Cancer Inst. 116, 1555\u20131561 (2024).","journal-title":"J. Natl. Cancer Inst."},{"key":"2820_CR238","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.cmet.2023.10.003","volume":"35","author":"AMY Zhang","year":"2023","unstructured":"Zhang, A. M. Y. et al. Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation. Cell Metab. 35, 2119\u20132135.e2115 (2023).","journal-title":"Cell Metab."},{"key":"2820_CR239","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.983160","volume":"13","author":"W Li","year":"2022","unstructured":"Li, W. et al. Insulin resistance and inflammation mediate the association of abdominal obesity with colorectal cancer risk. Front. Endocrinol. 13, 983160 (2022).","journal-title":"Front. Endocrinol."},{"key":"2820_CR240","doi-asserted-by":"publisher","first-page":"9683512","DOI":"10.1155\/2024\/9683512","volume":"2024","author":"H Fang","year":"2024","unstructured":"Fang, H. et al. Adipocytokines and inflammation in patients and a gerbil model: implications for obesity-related and nonobese diabetes. J. Diab. Res. 2024, 9683512 (2024).","journal-title":"J. Diab. Res."},{"key":"2820_CR241","doi-asserted-by":"publisher","first-page":"105127","DOI":"10.1016\/j.ebiom.2024.105127","volume":"103","author":"C Hateley","year":"2024","unstructured":"Hateley, C. et al. Multitissue profiling of oxylipins reveal a conserved upregulation of epoxide:diol ratio that associates with white adipose tissue inflammation and liver steatosis in obesity. EBioMedicine 103, 105127 (2024).","journal-title":"EBioMedicine"},{"key":"2820_CR242","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s42255-022-00525-9","volume":"4","author":"S Maqdasy","year":"2022","unstructured":"Maqdasy, S. et al. Impaired phosphocreatine metabolism in white adipocytes promotes inflammation. Nat. Metab. 4, 190\u2013202 (2022).","journal-title":"Nat. Metab."},{"key":"2820_CR243","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1136\/gutjnl-2021-325753","volume":"71","author":"E Belda","year":"2022","unstructured":"Belda, E. et al. Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism. Gut 71, 2463\u20132480 (2022).","journal-title":"Gut"},{"key":"2820_CR244","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Alcoholado, L. et al. Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer. Int. J. Mol. Sci. 21, (2020).","DOI":"10.3390\/ijms21186782"},{"key":"2820_CR245","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104670","volume":"93","author":"X Kang","year":"2023","unstructured":"Kang, X. et al. Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice. EBioMedicine 93, 104670 (2023).","journal-title":"EBioMedicine"},{"key":"2820_CR246","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.7150\/ijbs.86717","volume":"19","author":"X Shao","year":"2023","unstructured":"Shao, X. et al. High-fat diet promotes colitis-associated tumorigenesis by altering gut microbial butyrate metabolism. Int. J. Biol. Sci. 19, 5004\u20135019 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"2820_CR247","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100939","volume":"45","author":"V Madka","year":"2023","unstructured":"Madka, V. et al. Targeting IL-23 for the interception of obesity-associated colorectal cancer. Neoplasia 45, 100939 (2023).","journal-title":"Neoplasia"},{"key":"2820_CR248","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1194931","volume":"14","author":"S Parida","year":"2023","unstructured":"Parida, S. et al. Gut colonization with an obesity-associated enteropathogenic microbe modulates the premetastatic niches to promote breast cancer lung and liver metastasis. Front. Immunol. 14, 1194931 (2023).","journal-title":"Front. Immunol."},{"key":"2820_CR249","doi-asserted-by":"publisher","first-page":"104873","DOI":"10.1016\/j.ebiom.2023.104873","volume":"98","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial. EBioMedicine 98, 104873 (2023).","journal-title":"EBioMedicine"},{"key":"2820_CR250","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01487-9","volume":"15","author":"K Liu","year":"2023","unstructured":"Liu, K. et al. Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome. Clin. Epigenet. 15, 86 (2023).","journal-title":"Clin. Epigenet."},{"key":"2820_CR251","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1158\/0008-5472.CAN-23-1045","volume":"84","author":"V Pita-Grisanti","year":"2024","unstructured":"Pita-Grisanti, V. et al. Physical activity decreases inflammation and delays the development of obesity-associated pancreatic ductal adenocarcinoma. Cancer Res. 84, 3058\u20133071 (2024).","journal-title":"Cancer Res."},{"key":"2820_CR252","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/21551197.2018.1552226","volume":"38","author":"MC Lohman","year":"2019","unstructured":"Lohman, M. C. et al. Obesity, dietary inflammation, and frailty among older adults: evidence from the National Health and Nutrition Examination Survey. J. Nutr. Gerontol. Geriatr. 38, 18\u201332 (2019).","journal-title":"J. Nutr. Gerontol. Geriatr."},{"key":"2820_CR253","doi-asserted-by":"crossref","unstructured":"Shafiee, N. H. et al. Dietary Inflammatory Index, obesity, and the incidence of colorectal cancer: findings from a hospital-based case\u2012control study in Malaysia. Nutrients 15, (2023).","DOI":"10.3390\/nu15040982"},{"key":"2820_CR254","doi-asserted-by":"crossref","unstructured":"Son, D. S. et al. Intermittent fasting attenuates obesity-induced triple-negative breast cancer progression by disrupting cell cycle, epithelial\u2013mesenchymal transition, immune contexture, and proinflammatory signature. Nutrients 16, (2024).","DOI":"10.3390\/nu16132101"},{"key":"2820_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118222","volume":"258","author":"C Zhou","year":"2020","unstructured":"Zhou, C. et al. Fenugreek attenuates obesity-induced inflammation and improves insulin resistance through downregulation of iRhom2\/TACE. Life Sci. 258, 118222 (2020).","journal-title":"Life Sci."},{"key":"2820_CR256","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167142","volume":"1870","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Rabeprazole mitigates obesity-induced chronic inflammation and insulin resistance associated with increased M2-type macrophage polarization. Biochim. Biophys. Acta Mol. Basis Dis. 1870, 167142 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"2820_CR257","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216403","volume":"575","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. FABP4 in macrophages facilitates obesity-associated pancreatic cancer progression via the NLRP3\/IL-1\u03b2 axis. Cancer Lett. 575, 216403 (2023).","journal-title":"Cancer Lett."},{"key":"2820_CR258","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1080\/01635581.2025.2476779","volume":"77","author":"AA Goldbaum","year":"2025","unstructured":"Goldbaum, A. A. et al. The role of diet and the gut microbiota in the obesity-colorectal cancer link. Nutr. Cancer 77, 626\u2013639 (2025).","journal-title":"Nutr. Cancer"},{"key":"2820_CR259","doi-asserted-by":"crossref","unstructured":"Wang, J. Y. et al. GLP-1 receptor agonists for the treatment of obesity: role as a promising approach Front. Endocrinol. 14, 1085799 (2023).","DOI":"10.3389\/fendo.2023.1085799"},{"key":"2820_CR260","doi-asserted-by":"crossref","unstructured":"Szekeres, Z., Nagy, A., Jahner, K. & Szabados, E. Impact of selected glucagon-like peptide-1 receptor agonists on serum lipids, adipose tissue, and muscle metabolism\u2014a narrative review. Int. J. Mol. Sci. 25, 8214 (2024).","DOI":"10.3390\/ijms25158214"},{"key":"2820_CR261","doi-asserted-by":"crossref","unstructured":"Levy, S. et al. Differential effects of GLP-1 receptor agonists on cancer risk in obesity: a nationwide analysis of 1.1 million patients. Cancers 17, 78 (2025).","DOI":"10.3390\/cancers17010078"},{"key":"2820_CR262","unstructured":"Mehdi, S. F. et al. GLP-1 as a multifaceted anti-inflammatory mediator: implications for adipose macrophage biology. Front. Immunol. (2023)."},{"key":"2820_CR263","unstructured":"Borlaug, B. A. et al. Effects of tirzepatide on systemic inflammation and end-organ metrics. Nat. Med. (2024)."},{"key":"2820_CR264","doi-asserted-by":"crossref","unstructured":"Yuneva, M. Cold exposure as anticancer therapy. Cancer Cell (2022).","DOI":"10.1016\/j.ccell.2022.09.008"},{"key":"2820_CR265","doi-asserted-by":"crossref","unstructured":"Long, R. et al. Antibody\u2012drug conjugates in cancer therapy: applications and future advances. Front. Immunol. (2025).","DOI":"10.3389\/fimmu.2025.1516419"},{"key":"2820_CR266","unstructured":"Sakai, J. \u03b2-adrenergic signaling regulates a concerted thermogenic response in brown adipose tissue and white adipose tissue. Brain Nerve (2022)."},{"key":"2820_CR267","doi-asserted-by":"crossref","unstructured":"Vald\u00edvia, L. F. G. et al. Cold acclimation and pioglitazone combined increase thermogenic capacity of BAT and WAT but this does not translate into higher energy expenditure. Am. J. Physiol. Endocrinol. Metab. (2023).","DOI":"10.1152\/ajpendo.00217.2022"},{"key":"2820_CR268","doi-asserted-by":"publisher","first-page":"104349","DOI":"10.1016\/j.ebiom.2022.104349","volume":"86","author":"ME Straat","year":"2022","unstructured":"Straat, M. E. et al. Cold exposure induces dynamic changes in circulating triacylglycerol species, which is dependent on intracellular lipolysis: A randomized crossover trial. EBioMedicine 86, 104349 (2022).","journal-title":"EBioMedicine"},{"key":"2820_CR269","volume":"38","author":"S Shams","year":"2024","unstructured":"Shams, S. et al. Effects of swimming in cold water on lipolysis indicators via fibroblast growth factor-21 in male Wistar rats. Biochem. Biophys. Rep. 38, 101662 (2024).","journal-title":"Biochem. Biophys. Rep."},{"key":"2820_CR270","doi-asserted-by":"crossref","unstructured":"Voskarides, K. The double face of cold in cancer. Transl. Oncol. (2022).","DOI":"10.1016\/j.tranon.2022.101606"},{"key":"2820_CR271","doi-asserted-by":"crossref","unstructured":"Spiljar, M. et al. Cold exposure protects from neuroinflammation through immunologic reprogramming. Cell Metab. (2021).","DOI":"10.1101\/2020.08.28.269563"},{"key":"2820_CR272","doi-asserted-by":"crossref","unstructured":"Sharav\u2019eva, I. L. & Gein, S. V. Influence of acute cold stress on the secretion of IL-2, IL-4, IFN\u03b3, IL-12 in vivo by mouse splenocytes. Med. Immunol. (2022).","DOI":"10.15789\/1563-0625-IOA-2383"},{"key":"2820_CR273","doi-asserted-by":"crossref","unstructured":"Grazioso, T. P. & Djouder, N. A mechanistic view of the use of cold temperature in the treatment of cancer. iScience (2023).","DOI":"10.1016\/j.isci.2023.106511"},{"key":"2820_CR274","unstructured":"Kim, W., et al. NG-497, a potent and selective small-molecule ATGL inhibitor, modulates lipid metabolism in human systems. Endocrinology 166, (2025)."},{"key":"2820_CR275","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13046-022-02571-3","volume":"42","author":"M Rossi","year":"2023","unstructured":"Rossi, M. et al. Bromodomain and extraterminal inhibitors potentiate adipose triglyceride lipase-mediated lipolysis to suppress tumor growth. J. Exp. Clin. Cancer Res. 42, 22 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2820_CR276","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14859","volume":"8","author":"M Schweiger","year":"2017","unstructured":"Schweiger, M. et al. Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice. Nat. Commun. 8, 14859 (2017).","journal-title":"Nat. Commun."},{"key":"2820_CR277","doi-asserted-by":"publisher","first-page":"1415156","DOI":"10.3389\/fgene.2024.1415156","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang, S., Wu, S. & Peng, D. Dilated cardiomyopathy caused by mutation of the PNPLA2 gene: a case report and literature review. Front. Genet. 15, 1415156 (2024).","journal-title":"Front. Genet."},{"key":"2820_CR278","first-page":"999","volume":"19","author":"N Hakim","year":"2019","unstructured":"Hakim, N., Patel, R., DeVoe, C. & Saif, M. W. Why HALO 301 Failed and Implications for Treatment of Pancreatic Cancer. Expert Rev. Anticancer Ther. 19, 999\u20131001 (2019).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"2820_CR279","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1200\/JCO.20.00590","volume":"38","author":"E Van Cutsem","year":"2020","unstructured":"Van Cutsem, E. et al. Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma. J. Clin. Oncol. 38, 3185\u20133194 (2020).","journal-title":"J. Clin. Oncol."},{"key":"2820_CR280","first-page":"3117","volume":"89","author":"HA J\u00e4rvel\u00e4inen","year":"2023","unstructured":"J\u00e4rvel\u00e4inen, H. A. et al. Assessment of the pharmacokinetics, disposition and duration of action of the tumor-targeting peptide CEND-1 (iRGD). Br. J. Clin. Pharmacol. 89, 3117\u20133132 (2023).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2820_CR281","unstructured":"ClinicalTrials.gov. CEND-1 in combination with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma (CENDIFOX). (2018)."},{"key":"2820_CR282","first-page":"1898","volume":"127","author":"A Dean","year":"2022","unstructured":"Dean, A. et al. Dual \u03b1V-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine in metastatic pancreatic cancer: a phase 1 study. Br. J. Cancer 127, 1898\u20131907 (2022).","journal-title":"Br. J. Cancer"},{"key":"2820_CR283","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11011-024-01454-0","volume":"40","author":"CS Ernesto","year":"2025","unstructured":"Ernesto, C. S. et al. LCN2 blockade mitigating metabolic dysregulation and redefining appetite control in type 2 diabetes. Metab. Brain Dis. 40, 97 (2025).","journal-title":"Metab. Brain Dis."},{"key":"2820_CR284","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110910","volume":"39","author":"A Fougerat","year":"2022","unstructured":"Fougerat, A. et al. ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPAR\u03b1 activity. Cell Rep. 39, 110910 (2022).","journal-title":"Cell Rep."},{"key":"2820_CR285","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cmet.2024.10.018","volume":"37","author":"E Mouisel","year":"2025","unstructured":"Mouisel, E. et al. Cold-induced thermogenesis requires neutral-lipase-mediated intracellular lipolysis in brown adipocytes. Cell Metab. 37, 429\u2013440.e425 (2025).","journal-title":"Cell Metab."},{"key":"2820_CR286","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1158\/0008-5472.CAN-23-0555","volume":"84","author":"D Awad","year":"2024","unstructured":"Awad, D. et al. Adipose triglyceride lipase is a therapeutic target in advanced prostate cancer that promotes metabolic plasticity. Cancer Res 84, 703\u2013724 (2024).","journal-title":"Cancer Res"},{"key":"2820_CR287","first-page":"999","volume":"19","author":"N Hakim","year":"2019","unstructured":"Hakim, N., Patel, R., DeVoe, C. & Saif, M. W. Why HALO 301 failed and implications for the treatment of pancreatic cancer. Expert Rev. Anticancer Ther. 19, 999\u20131001 (2019).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"2820_CR288","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1200\/JCO.20.00590","volume":"38","author":"E Van Cutsem","year":"2020","unstructured":"Van Cutsem, E. et al. Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma (HALO 301). J. Clin. Oncol. 38, 3185\u20133194 (2020).","journal-title":"J. Clin. Oncol."},{"key":"2820_CR289","first-page":"943","volume":"7","author":"A Dean","year":"2022","unstructured":"Dean, A. et al. Dual \u03b1V-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine in metastatic pancreatic cancer: a phase 1 study. Gastroenterol. Hepatol. 7, 943\u2013951 (2022).","journal-title":"Gastroenterol. Hepatol."},{"key":"2820_CR290","doi-asserted-by":"publisher","first-page":"101590","DOI":"10.1016\/j.xcrm.2024.101590","volume":"5","author":"Y Pan","year":"2024","unstructured":"Pan, Y. et al. Glycoengineering-based anti-PD-1\u2013iRGD peptide conjugate boosts antitumor efficacy through T-cell engagement. Cell Rep. Med. 5, 101590 (2024).","journal-title":"Cell Rep. Med."},{"key":"2820_CR291","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.3390\/cancers16132438","volume":"16","author":"A Argentiero","year":"2024","unstructured":"Argentiero, A. et al. Decoding the intricate landscape of pancreatic cancer: insights into tumor biology, microenvironment, and therapeutic interventions. Cancers 16, 2438 (2024).","journal-title":"Cancers"},{"key":"2820_CR292","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s13402-021-00634-9","volume":"44","author":"U Mehraj","year":"2021","unstructured":"Mehraj, U. et al. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: new challenges and therapeutic opportunities. Cell Oncol. Dordr. 44, 1209\u20131229 (2021).","journal-title":"Cell Oncol. Dordr."},{"key":"2820_CR293","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/CritRevOncog.2024053419","volume":"29","author":"MK Gupta","year":"2024","unstructured":"Gupta, M. K., Gouda, G. & Vadde, R. Role of the tumor microenvironment in mediating resistance to anti-HER2 antibodies. Crit. Rev. Oncog. 29, 43\u201354 (2024).","journal-title":"Crit. Rev. Oncog."},{"key":"2820_CR294","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18736-7","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang, T. et al. Cancer-associated adipocytes promote breast cancer progression through metabolic reprogramming. Nat. Commun. 11, 4976 (2020).","journal-title":"Nat. Commun."},{"key":"2820_CR295","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","volume":"71","author":"B Dirat","year":"2011","unstructured":"Dirat, B. et al. Cancer-associated adipocytes: key players in breast cancer progression. Cancer Res. 71, 2455\u20132465 (2011).","journal-title":"Cancer Res."},{"key":"2820_CR296","first-page":"824316","volume":"12","author":"X Zhuang","year":"2022","unstructured":"Zhuang, X., Zhang, H. & Hu, G. Phenotypic and functional diversity of cancer-associated adipocytes in the tumor microenvironment. Front. Oncol. 12, 824316 (2022).","journal-title":"Front. Oncol."},{"key":"2820_CR297","first-page":"100970","volume":"4","author":"Y Tan","year":"2023","unstructured":"Tan, Y. et al. Cancer-associated adipocyte-derived cytokines orchestrate breast cancer invasion and immune evasion. Cell Rep. Med. 4, 100970 (2023).","journal-title":"Cell Rep. Med."},{"key":"2820_CR298","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1158\/1538-7445.AM2019-4441","volume":"79","author":"Q Wu","year":"2019","unstructured":"Wu, Q. et al. FABP4 as a mediator of tumor\u2013adipocyte metabolic crosstalk. Cancer Res. 79, 4441\u20134455 (2019).","journal-title":"Cancer Res."},{"key":"2820_CR299","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s42255-019-0152-6","volume":"2","author":"K Sun","year":"2020","unstructured":"Sun, K., Kusminski, C. M. & Scherer, P. E. Single-cell dissection of adipocyte heterogeneity in the tumor niche. Nat. Metab. 2, 97\u2013109 (2020).","journal-title":"Nat. Metab."},{"key":"2820_CR300","first-page":"917","volume":"33","author":"M Zhang","year":"2021","unstructured":"Zhang, M. et al. Lineage tracing reveals adipocyte-to-fibroblast transition in the tumor microenvironment. Cell Metab. 33, 917\u2013932 (2021).","journal-title":"Cell Metab."},{"key":"2820_CR301","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cac2.12479","volume":"43","author":"W Liu","year":"2023","unstructured":"Liu, W. et al. JARID2 coordinates with the NuRD complex to facilitate breast tumorigenesis through response to adipocyte-derived leptin. Cancer Commun. 43, 1117\u20131142 (2023).","journal-title":"Cancer Commun."},{"key":"2820_CR302","doi-asserted-by":"crossref","unstructured":"Naimo, G. D. et al. Adiponectin influences the behavior of stem cells in hormone-resistant breast cancer. Cells. 14, (2025).","DOI":"10.3390\/cells14040286"},{"key":"2820_CR303","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1158\/2159-8290.CD-17-1371","volume":"8","author":"M Zhang","year":"2018","unstructured":"Zhang, M. et al. Adipocyte-derived lipids mediate melanoma progression via FATP proteins. Cancer Discov. 8, 1006\u20131025 (2018).","journal-title":"Cancer Discov."},{"key":"2820_CR304","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.cmet.2022.07.010","volume":"34","author":"P Zhang","year":"2022","unstructured":"Zhang, P. et al. Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment. Cell Metab. 34, 1359\u20131376.e1357 (2022).","journal-title":"Cell Metab."},{"key":"2820_CR305","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.3390\/ijms24097745","volume":"24","author":"LYM Michel","year":"2023","unstructured":"Michel, L. Y. M. Extracellular vesicles in adipose tissue communication with the healthy and pathological heart. Int. J. Mol. Sci. 24, 7745 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2820_CR306","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/biomedicines11020422","volume":"11","author":"T Camino","year":"2023","unstructured":"Camino, T., Lago-Baameiro, N. & Pardo, M. Extracellular vesicles as carriers of adipokines and their role in obesity. Biomedicines 11, 422 (2023).","journal-title":"Biomedicines"},{"key":"2820_CR307","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/pharmaceutics12050402","volume":"12","author":"R Munteanu","year":"2020","unstructured":"Munteanu, R. et al. Adipocyte-based cell therapy in oncology: the role of cancer-associated adipocytes and their reinterpretation as delivery platforms. Pharmaceutics 12, 402 (2020).","journal-title":"Pharmaceutics"},{"key":"2820_CR308","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20500-w","volume":"12","author":"A Kumar","year":"2021","unstructured":"Kumar, A. et al. High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance. Nat. Commun. 12, 213 (2021).","journal-title":"Nat. Commun."},{"key":"2820_CR309","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature14581","volume":"523","author":"SA Melo","year":"2015","unstructured":"Melo, S. A. et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523, 177\u2013182 (2015).","journal-title":"Nature"},{"key":"2820_CR310","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04506-4","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts. Cell Death Dis. 13, 57 (2022).","journal-title":"Cell Death Dis."},{"key":"2820_CR311","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1158\/0008-5472.CAN-21-0914","volume":"82","author":"L Ippolito","year":"2022","unstructured":"Ippolito, L. et al. Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer. Cancer Res. 82, 1267\u20131282 (2022).","journal-title":"Cancer Res."},{"key":"2820_CR312","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ccell.2023.05.001","volume":"41","author":"JK Minami","year":"2023","unstructured":"Minami, J. K. et al. CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis. Cancer Cell 41, 1048\u20131060.e1049 (2023).","journal-title":"Cancer Cell"},{"key":"2820_CR313","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abk2756","volume":"14","author":"G Wang","year":"2022","unstructured":"Wang, G. et al. Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis. Sci. Transl. Med. 14, eabk2756 (2022).","journal-title":"Sci. Transl. Med."},{"key":"2820_CR314","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41586-020-2969-2","volume":"588","author":"X Jin","year":"2020","unstructured":"Jin, X. et al. A metastasis map of human cancer cell lines. Nature 588, 331\u2013336 (2020).","journal-title":"Nature"},{"key":"2820_CR315","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25354-4","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat. Commun. 12, 5103 (2021).","journal-title":"Nat. Commun."},{"key":"2820_CR316","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2217\/bmm-2020-0460","volume":"14","author":"MI Sawada","year":"2020","unstructured":"Sawada, M. I., GD, S. F. & Passarelli, M. Cholesterol derivatives and breast cancer: oxysterols driving tumor growth and metastasis. Biomark. Med. 14, 1299\u20131302 (2020).","journal-title":"Biomark. Med."},{"key":"2820_CR317","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/0008-5472.CAN-22-3490","volume":"83","author":"CM Deng","year":"2023","unstructured":"Deng, C. M. et al. ANO1 reprograms cholesterol metabolism and the tumor microenvironment to promote cancer metastasis. Cancer Res. 83, 1851\u20131865 (2023).","journal-title":"Cancer Res."},{"key":"2820_CR318","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.cmet.2019.02.016","volume":"29","author":"P Goossens","year":"2019","unstructured":"Goossens, P. et al. Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression. Cell Metab. 29, 1376\u20131389.e1374 (2019).","journal-title":"Cell Metab."},{"key":"2820_CR319","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1003419","volume":"13","author":"S Xie","year":"2022","unstructured":"Xie, S. et al. Single-cell transcriptome analysis reveals heterogeneity and convergence of the tumor microenvironment in colorectal cancer. Front. Immunol. 13, 1003419 (2022).","journal-title":"Front. Immunol."},{"key":"2820_CR320","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1538-7445.AM2022-2200","volume":"82","author":"N Zaidi","year":"2022","unstructured":"Zaidi, N. et al. Dietary palmitic acid enhances metastatic potential via CD36. Cancer Res. 82, 1234 (2022).","journal-title":"Cancer Res."},{"key":"2820_CR321","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43554-y","volume":"15","author":"W Zhou","year":"2024","unstructured":"Zhou, W. et al. CD36-mediated lipid uptake promotes metastasis-initiating cells in cancer. Nat. Commun. 15, 221 (2024).","journal-title":"Nat. Commun."},{"key":"2820_CR322","first-page":"4511","volume":"42","author":"W Feng","year":"2023","unstructured":"Feng, W. et al. FABP4 links adipocyte lipolysis to tumor fatty acid oxidation. Oncogene 42, 4511 (2023).","journal-title":"Oncogene"},{"key":"2820_CR323","first-page":"2312","volume":"34","author":"A Guerrero-Rodr\u00edguez","year":"2022","unstructured":"Guerrero-Rodr\u00edguez, A. et al. CD36 and FABP cooperation in adipocyte\u2013tumor metabolic coupling. Cell Metab. 34, 2312 (2022).","journal-title":"Cell Metab."},{"key":"2820_CR324","first-page":"1123","volume":"14","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Exosomal regulation of ferroptosis in tumor\u2013adipocyte crosstalk. Front. Oncol. 14, 1123 (2024).","journal-title":"Front. Oncol."},{"key":"2820_CR325","first-page":"215","volume":"539","author":"Y Tang","year":"2022","unstructured":"Tang, Y. et al. PGC1\u03b1\/CEBPB\/CPT1A axis sustains FAO-mediated chemoresistance. Cancer Lett. 539, 215 (2022).","journal-title":"Cancer Lett."},{"key":"2820_CR326","doi-asserted-by":"crossref","unstructured":"Lo Iacono, M. et al. Targeting of the peritumoral adipose tissue microenvironment as an innovative antitumor therapeutic strategy. Biomolecules. 12, (2022).","DOI":"10.3390\/biom12050702"},{"key":"2820_CR327","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s13287-024-03931-w","volume":"15","author":"G Di Rocco","year":"2024","unstructured":"Di Rocco, G., Trivisonno, A., Trivisonno, G. & Toietta, G. Dissecting human adipose tissue heterogeneity using single-cell omics technologies. Stem Cell Res. Ther. 15, 322 (2024).","journal-title":"Stem Cell Res. Ther."},{"key":"2820_CR328","first-page":"455","volume":"6","author":"L Ma","year":"2024","unstructured":"Ma, L. et al. CPT1A-driven fatty acid oxidation underlies radioresistance in cancer cells. Nat. Metab. 6, 455 (2024).","journal-title":"Nat. Metab."},{"key":"2820_CR329","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1158\/1078-0432.CCR-23-1957","volume":"30","author":"A Nandi","year":"2024","unstructured":"Nandi, A. et al. Targeting fatty acid oxidation improves HER2+ breast cancer therapy response. Clin. Cancer Res. 30, 1189 (2024).","journal-title":"Clin. Cancer Res."},{"key":"2820_CR330","first-page":"2135","volume":"40","author":"H Yin","year":"2021","unstructured":"Yin, H. et al. Adipocyte-derived exosomes remodel lipid metabolism by upregulating SCD1. Oncogene 40, 2135 (2021).","journal-title":"Oncogene"},{"key":"2820_CR331","doi-asserted-by":"crossref","first-page":"108718","DOI":"10.1016\/j.celrep.2021.108718","volume":"34","author":"G Luis","year":"2021","unstructured":"Luis, G. et al. Stearoyl-CoA desaturase 1 regulates ferroptosis sensitivity in cancer. Cell Rep. 34, 108718 (2021).","journal-title":"Cell Rep."},{"key":"2820_CR332","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27909-x","volume":"13","author":"M Luo","year":"2022","unstructured":"Luo, M. et al. SCD1-mediated MUFA biosynthesis confers ferroptosis resistance. Nat. Commun. 13, 174 (2022).","journal-title":"Nat. Commun."},{"key":"2820_CR333","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01936-w","volume":"23","author":"J Wu","year":"2024","unstructured":"Wu, J. et al. Adipocyte exosome cargo protects tumor cells from lipid peroxidation. Mol. Cancer 23, 45 (2024).","journal-title":"Mol. Cancer"},{"key":"2820_CR334","doi-asserted-by":"crossref","unstructured":"Pallegar, N. K. & Christian, S. L. in Tumor Microenvironment: Non-Hematopoietic Cells (ed. Alexander Birbrair) 1\u201313 (Springer International Publishing, 2020)","DOI":"10.1007\/978-3-030-37184-5_1"},{"key":"2820_CR335","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1158\/0008-5472.CAN-23-2526","volume":"84","author":"SJ Conner","year":"2024","unstructured":"Conner, S. J. et al. Obesity induces temporally regulated alterations in the extracellular matrix that drive breast tumor invasion and metastasis. Cancer Res. 84, 2761\u20132775 (2024).","journal-title":"Cancer Res."},{"key":"2820_CR336","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-3-030-59038-3_10","volume":"1296","author":"CS Curran","year":"2020","unstructured":"Curran, C. S. & Ponik, S. M. The mammary tumor microenvironment. Adv. Exp. Med. Biol. 1296, 163\u2013181 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2820_CR337","doi-asserted-by":"crossref","unstructured":"Jiramongkol, Y. & Lam, E. W. F. in Tumor Microenvironment: The Main Driver of Metabolic Adaptation (ed. Serpa, J.) 125\u2013142 (Springer International Publishing, 2020)","DOI":"10.1007\/978-3-030-34025-4_7"},{"key":"2820_CR338","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400219","volume":"13","author":"N Jia","year":"2024","unstructured":"Jia, N. et al. Membrane fusion liposomes deliver antifibrotic and chemotherapeutic drugs sequentially to enhance tumor treatment efficacy by reshaping tumor microenvironment. Adv. Health. Mater. 13, e2400219 (2024).","journal-title":"Adv. Health. Mater."},{"key":"2820_CR339","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03165-9","volume":"23","author":"Y Yao","year":"2025","unstructured":"Yao, Y. et al. Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multidimensional treatment of ovarian cancer. J. Nanobiotechnol. 23, 83 (2025).","journal-title":"J. Nanobiotechnol."},{"key":"2820_CR340","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117266","volume":"239","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Adipocyte-derived exosomes promote the progression of triple-negative breast cancer through circCRIM1-dependent OGA activation. Environ. Res. 239, 117266 (2023).","journal-title":"Environ. Res."},{"key":"2820_CR341","doi-asserted-by":"publisher","first-page":"867100","DOI":"10.3389\/fragi.2022.867100","volume":"3","author":"IR Siqueira","year":"2022","unstructured":"Siqueira, I. R. et al. Circulating extracellular vesicles and particles derived from adipocytes: the potential role in spreading MicroRNAs associated with cellular senescence. Front. Aging 3, 867100 (2022).","journal-title":"Front. Aging"},{"key":"2820_CR342","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01806-4","volume":"22","author":"ME Williams","year":"2024","unstructured":"Williams, M. E. et al. Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer. Cell Commun. Signal 22, 443 (2024).","journal-title":"Cell Commun. Signal"},{"key":"2820_CR343","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35305-2","volume":"13","author":"D Zhao","year":"2022","unstructured":"Zhao, D. et al. Exosomal miR-1304-3p promotes breast cancer progression in African Americans by activating cancer-associated adipocytes. Nat. Commun. 13, 7734 (2022).","journal-title":"Nat. Commun."},{"key":"2820_CR344","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/ijms22031444","volume":"22","author":"D-V Pham","year":"2021","unstructured":"Pham, D.-V. & Park, P.-H. Tumor metabolic reprogramming by adipokines as a critical driver of obesity-associated cancer progression. Int. J. Mol. Sci. 22, 1444 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2820_CR345","doi-asserted-by":"crossref","unstructured":"Maurya, S. K., Bhattacharya, N., Bhattacharya, A. & Senapati, S. in Obesity and Cancer (eds Kumar, S. & Gupta, S.) 49\u201379 (Springer Singapore, 2021).","DOI":"10.1007\/978-981-16-1846-8_4"},{"key":"2820_CR346","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2306776121","volume":"121","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation. Proc. Natl. Acad. Sci. USA 121, e2306776121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2820_CR347","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103302","volume":"75","author":"B Sun","year":"2024","unstructured":"Sun, B. et al. FDX1 downregulation activates mitophagy and the PI3K\/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production. Redox Biol. 75, 103302 (2024).","journal-title":"Redox Biol."},{"key":"2820_CR348","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216035","volume":"555","author":"C An","year":"2023","unstructured":"An, C. et al. The molecular link between obesity and genomic instability in cancer development. Cancer Lett. 555, 216035 (2023).","journal-title":"Cancer Lett."},{"key":"2820_CR349","doi-asserted-by":"crossref","unstructured":"Ray, A. & Acharya, D. in Functional Foods in Cancer Prevention and Therapy (ed. Kabir, Y.) 73\u201398 (Academic Press, 2020).","DOI":"10.1016\/B978-0-12-816151-7.00005-3"},{"key":"2820_CR350","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1002\/mc.22428","volume":"55","author":"L Cai","year":"2016","unstructured":"Cai, L. et al. Adiponectin induces CXCL1 secretion from cancer cells and promotes tumor angiogenesis by inducing stromal fibroblast senescence. Mol. Carcinog. 55, 1796\u20131806 (2016).","journal-title":"Mol. Carcinog."},{"key":"2820_CR351","doi-asserted-by":"publisher","DOI":"10.1177\/1010428319842699","volume":"42","author":"YT Ouh","year":"2019","unstructured":"Ouh, Y. T. et al. CXC chemokine ligand 1 mediates adiponectin-induced angiogenesis in ovarian cancer. Tumor Biol. 42, 1010428319842699 (2019).","journal-title":"Tumor Biol."},{"key":"2820_CR352","doi-asserted-by":"publisher","first-page":"E1038","DOI":"10.1152\/ajpendo.00299.2014","volume":"307","author":"M Kiezun","year":"2014","unstructured":"Kiezun, M. et al. Adiponectin expression in the porcine pituitary during the estrous cycle and its effect on LH and FSH secretion. Am. J. Physiol. Endocrinol. Metab. 307, E1038\u2013E1046 (2014).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2820_CR353","doi-asserted-by":"crossref","unstructured":"Li, C. et al. Adiponectin inhibits the progression of obesity-associated papillary thyroid carcinoma through autophagy. Endocrinology 165, (2024).","DOI":"10.1210\/endocr\/bqae030"},{"key":"2820_CR354","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/eci.12445","volume":"45","author":"K Michalakis","year":"2015","unstructured":"Michalakis, K. et al. In prostate cancer, low adiponectin levels are not associated with insulin resistance. Eur. J. Clin. Invest 45, 572\u2013578 (2015).","journal-title":"Eur. J. Clin. Invest"},{"key":"2820_CR355","doi-asserted-by":"crossref","unstructured":"Xiao, H. et al. Adiponectin deficiency prevents chronic colitis-associated colonic fibrosis by inhibiting CXCL13 production. J. Adv. Res. (2024).","DOI":"10.1016\/j.jare.2024.12.032"},{"key":"2820_CR356","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3892\/or.2022.8377","volume":"48","author":"KB Park","year":"2022","unstructured":"Park, K. B. et al. Leptin stimulates migration and invasion and maintains cancer stem\u2011like properties in gastric cancer cells. Oncol. Rep. 48, 162 (2022).","journal-title":"Oncol. Rep."},{"key":"2820_CR357","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/gutjnl-2022-328035","volume":"72","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. A novel peptide protects against diet-induced obesity by suppressing appetite and modulating the gut microbiota. Gut 72, 686\u2013698 (2023).","journal-title":"Gut"},{"key":"2820_CR358","doi-asserted-by":"publisher","first-page":"7139","DOI":"10.7314\/APJCP.2015.16.16.7139","volume":"16","author":"EY Elsayed","year":"2015","unstructured":"Elsayed, E. Y., Mosalam, N. A. & Mohamed, N. R. Resistin and insulin resistance: a link between inflammation and hepatocarcinogenesis. Asian Pac. J. Cancer Prev. 16, 7139\u20137142 (2015).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"2820_CR359","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1055\/a-1492-3077","volume":"53","author":"Rzepa","year":"2021","unstructured":"Rzepa et al. Resistin is associated with inflammation and renal function, but not with insulin resistance in type 2 diabetes. Horm. Metab. Res. 53, 478\u2013484 (2021).","journal-title":"Horm. Metab. Res."},{"key":"2820_CR360","doi-asserted-by":"publisher","first-page":"0326","DOI":"10.34133\/research.0326","volume":"7","author":"HM Yang","year":"2024","unstructured":"Yang, H. M. et al. Resistin regulates inflammation and insulin resistance in humans via the endocannabinoid system. Research 7, 0326 (2024).","journal-title":"Research"},{"key":"2820_CR361","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1111\/ajco.12090","volume":"12","author":"M Chen","year":"2016","unstructured":"Chen, M. et al. Association of plasma visfatin with risk of colorectal cancer: an observational study of Chinese patients. Asia Pac. J. Clin. Oncol. 12, e65\u2013e74 (2016).","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"2820_CR362","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149931","volume":"718","author":"J Zhao","year":"2024","unstructured":"Zhao, J. et al. An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer. Biochem. Biophys. Res. Commun. 718, 149931 (2024).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2820_CR363","doi-asserted-by":"crossref","unstructured":"Zhao, Q. et al. Visfatin inhibits colon cancer apoptosis and decreases chemosensitivity to 5\u2011FU by promoting the SDF\u20111\/CXCR4\/Akt axis. Int. J. Oncol. 60, (2022).","DOI":"10.3892\/ijo.2022.5365"},{"key":"2820_CR364","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.2337\/db15-0617","volume":"65","author":"C Martinerie","year":"2016","unstructured":"Martinerie, C. et al. NOV\/CCN3: a new adipocytokine involved in obesity-associated insulin resistance. Diabetes 65, 2502\u20132515 (2016).","journal-title":"Diabetes"},{"key":"2820_CR365","doi-asserted-by":"crossref","unstructured":"Liang, T. et al. NOV\/CCN3 promotes cell migration and invasion in intrahepatic cholangiocarcinoma via miR-92a-3p. Genes 12, (2021).","DOI":"10.3390\/genes12111659"},{"key":"2820_CR366","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/13813455.2021.1988110","volume":"130","author":"Z Tahergorabi","year":"2024","unstructured":"Tahergorabi, Z. et al. Crosstalk between obesity and cancer: a role for adipokines. Arch. Physiol. Biochem. 130, 155\u2013168 (2024).","journal-title":"Arch. Physiol. Biochem."},{"key":"2820_CR367","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2085432","volume":"11","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression. OncoImmunology 11, 2085432 (2022).","journal-title":"OncoImmunology"},{"key":"2820_CR368","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206001","volume":"10","author":"D Wen","year":"2023","unstructured":"Wen, D. et al. Adipocytes encapsulating telratolimod recruit and polarize tumor-associated macrophages for cancer immunotherapy. Adv. Sci. 10, 2206001 (2023).","journal-title":"Adv. Sci."},{"key":"2820_CR369","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.3390\/cancers14225684","volume":"14","author":"J Li","year":"2022","unstructured":"Li, J. & Xu, R. Obesity-Associated ECM Remodeling in Cancer Progression. Cancers 14, 5684 (2022).","journal-title":"Cancers"},{"key":"2820_CR370","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01744-8","volume":"22","author":"Z Yuan","year":"2023","unstructured":"Yuan, Z. et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol. Cancer 22, 48 (2023).","journal-title":"Mol. Cancer"},{"key":"2820_CR371","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06481-4","volume":"15","author":"X Cui","year":"2024","unstructured":"Cui, X. et al. RUNX1\/NPM1\/H3K4me3 complex contributes to extracellular matrix remodeling by enhancing FOSL2 transcriptional activation in glioblastoma. Cell Death Dis. 15, 98 (2024).","journal-title":"Cell Death Dis."},{"key":"2820_CR372","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13641-y","volume":"25","author":"EHH Famili-Youth","year":"2025","unstructured":"Famili-Youth, E. H. H. et al. Aberrant expression of collagen type X in solid tumor stroma is associated with EMT, immunosuppressive and pro-metastatic pathways, bone marrow stromal cell signatures, and poor survival prognosis. BMC Cancer 25, 247 (2025).","journal-title":"BMC Cancer"},{"key":"2820_CR373","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.942774","volume":"12","author":"Y Jo","year":"2022","unstructured":"Jo, Y. et al. Machine learning-featured Secretogranin V is a circulating diagnostic biomarker for pancreatic adenocarcinomas associated with adipopenia. Front. Oncol. 12, 942774 (2022).","journal-title":"Front. Oncol."},{"key":"2820_CR374","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.humpath.2023.12.005","volume":"147","author":"SE Kilpatrick","year":"2024","unstructured":"Kilpatrick, S. E. Atypical lipomatous tumor\/well differentiated liposarcoma and related mimics with updates. When is molecular testing most cost-effective, necessary, and indicated?. Hum. Pathol. 147, 82\u201391 (2024).","journal-title":"Hum. Pathol."},{"key":"2820_CR375","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12519-9","volume":"24","author":"P Grochowski","year":"2024","unstructured":"Grochowski, P. et al. The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma. BMC Cancer 24, 768 (2024).","journal-title":"BMC Cancer"},{"key":"2820_CR376","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/path.5810","volume":"256","author":"B Grosser","year":"2022","unstructured":"Grosser, B. et al. Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor-promoting adipocytes. J. Pathol. 256, 71\u201382 (2022).","journal-title":"J. Pathol."},{"key":"2820_CR377","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.4251\/wjgo.v16.i7.3011","volume":"16","author":"JR Shang","year":"2024","unstructured":"Shang, J. R. et al. Adipocytes impact on gastric cancer progression: prognostic insights and molecular features. World J. Gastrointest. Oncol. 16, 3011\u20133031 (2024).","journal-title":"World J. Gastrointest. Oncol."},{"key":"2820_CR378","doi-asserted-by":"crossref","unstructured":"Lee, J. W. et al. Clinical significance of peritumoral adipose tissue PET\/CT imaging features for predicting axillary lymph node metastasis in patients with breast cancer. J. Pers. Med. 11, (2021).","DOI":"10.3390\/jpm11101029"},{"key":"2820_CR379","doi-asserted-by":"publisher","first-page":"101719","DOI":"10.1016\/j.xcrm.2024.101719","volume":"5","author":"YJ Qi","year":"2024","unstructured":"Qi, Y. J. et al. Radiomics in breast cancer: current advances and future directions. Cell Rep. Med. 5, 101719 (2024).","journal-title":"Cell Rep. Med."},{"key":"2820_CR380","doi-asserted-by":"crossref","unstructured":"Lee, J. W. et al. Peritumoral adipose tissue features derived from [(18)F]fluoro-2-deoxy-2-d-glucose positron emission tomography\/computed tomography as predictors for response to neoadjuvant chemotherapy in breast cancer patients. J. Pers. Med. 14, (2024).","DOI":"10.3390\/jpm14090952"},{"key":"2820_CR381","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.2147\/OTT.S256654","volume":"13","author":"J Wang","year":"2020","unstructured":"Wang, J. & Pan, W. The biological role of the collagen alpha-3 (VI) chain and its cleaved C5 domain fragment endotrophin in cancer. Onco Targets Ther. 13, 5779\u20135793 (2020).","journal-title":"Onco Targets Ther."},{"key":"2820_CR382","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-00747-3","volume":"15","author":"W Zhang","year":"2025","unstructured":"Zhang, W. et al. The potential of secretogranin V as a prognostic biomarker in non-small cell lung cancer. Sci. Rep. 15, 16589 (2025).","journal-title":"Sci. Rep."},{"key":"2820_CR383","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202200161","volume":"7","author":"B Li","year":"2023","unstructured":"Li, B. et al. Macrophages in tumor-associated adipose microenvironment accelerate tumor progression. Adv. Biol. 7, e2200161 (2023).","journal-title":"Adv. Biol."},{"key":"2820_CR384","doi-asserted-by":"crossref","unstructured":"Moorman, H. R. et al. Osteopontin: a key regulator of tumor progression and immunomodulation. Cancers. 12, (2020).","DOI":"10.3390\/cancers12113379"},{"key":"2820_CR385","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53023-9","volume":"15","author":"Y Gu","year":"2024","unstructured":"Gu, Y. et al. Osteopontin is a therapeutic target that drives breast cancer recurrence. Nat. Commun. 15, 9174 (2024).","journal-title":"Nat. Commun."},{"key":"2820_CR386","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/21623945.2021.1965314","volume":"10","author":"Q Wang","year":"2021","unstructured":"Wang, Q., Wang, Y. & Xu, D. The roles of T cells in obese adipose tissue inflammation. Adipocyte 10, 435\u2013445 (2021).","journal-title":"Adipocyte"},{"key":"2820_CR387","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41423-021-00812-7","volume":"19","author":"E Hern\u00e1ndez-Garc\u00eda","year":"2022","unstructured":"Hern\u00e1ndez-Garc\u00eda, E. et al. Conventional type 1 dendritic cells protect against age-related adipose tissue dysfunction and obesity. Cell. Mol. Immunol. 19, 260\u2013275 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"2820_CR388","doi-asserted-by":"crossref","unstructured":"Brombacher, E. C. & Everts, B. Shaping of dendritic cell function by the metabolic micro-environment. Front. Endocrinol. 11, (2020).","DOI":"10.3389\/fendo.2020.00555"},{"key":"2820_CR389","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/mas.21382","volume":"33","author":"ED Merkley","year":"2014","unstructured":"Merkley, E. D. et al. The succinated proteome. Mass Spectrom. Rev. 33, 98\u2013109 (2014).","journal-title":"Mass Spectrom. Rev."},{"key":"2820_CR390","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s13238-021-00897-w","volume":"13","author":"Q Ma","year":"2022","unstructured":"Ma, Q. et al. Governing glutaminolysis by regulation of glutaminase succinylation. Protein Cell 13, 163\u2013166 (2022).","journal-title":"Protein Cell"},{"key":"2820_CR391","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41418-023-01240-y","volume":"31","author":"P Teng","year":"2024","unstructured":"Teng, P. et al. SIRT5-mediated ME2 desuccinylation promotes cancer growth by enhancing mitochondrial respiration. Cell Death Differ 31, 65\u201377 (2024).","journal-title":"Cell Death Differ"},{"key":"2820_CR392","doi-asserted-by":"crossref","unstructured":"Yang, H. et al. SIRT5-mediated GLS and GDH desuccinylation attenuates the autophagy of bovine mammary epithelial cells induced by ammonia. Cell Signal. 127, 111570 (2025).","DOI":"10.1016\/j.cellsig.2024.111570"},{"key":"2820_CR393","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.gpb.2022.02.004","volume":"21","author":"OK Kwon","year":"2023","unstructured":"Kwon, O. K. et al. LDHA desuccinylase Sirtuin 5 as a novel cancer metastatic stimulator in aggressive prostate cancer. Genom. Proteom. Bioinform 21, 177\u2013189 (2023).","journal-title":"Genom. Proteom. Bioinform"},{"key":"2820_CR394","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s41418-023-01157-6","volume":"30","author":"L Shi","year":"2023","unstructured":"Shi, L. et al. LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer. Cell Death Differ. 30, 1517\u20131532 (2023).","journal-title":"Cell Death Differ."},{"key":"2820_CR395","doi-asserted-by":"crossref","unstructured":"Adejor, J. et al. Impact of lysine succinylation on the biology of fungi. Curr. Issues Mol. Biol. 46, 1020\u20131046 (2024).","DOI":"10.3390\/cimb46020065"},{"key":"2820_CR396","doi-asserted-by":"crossref","unstructured":"Albakova, Z. et al. HSP90 multi-functionality in cancer. Front. Immunol. 15, 1436973 (2024).","DOI":"10.3389\/fimmu.2024.1436973"},{"key":"2820_CR397","doi-asserted-by":"crossref","unstructured":"Backe, S. J., Sager, R. A., Woodford, M. R., Makedon, A. M. & Mollapour, M. Post-translational modifications of Hsp90 and translating the chaperone code. J. Biol. Chem. 295, 11099\u201311117 (2020).","DOI":"10.1074\/jbc.REV120.011833"},{"key":"2820_CR398","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05215-6","volume":"22","author":"Y Han","year":"2024","unstructured":"Han, Y. et al. KAT2A-promoted succinylation of Sp1 activates mTOR. J. Transl. Med. 22, 427 (2024).","journal-title":"J. Transl. Med."},{"key":"2820_CR399","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41420-022-01211-1","volume":"8","author":"K Lu","year":"2022","unstructured":"Lu, K. et al. A review of the mechanism of succinylation in cancer. Cell Death Discov. 8, 457 (2022).","journal-title":"Cell Death Discov."},{"key":"2820_CR400","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051009","volume":"22","author":"LZ Shahidian","year":"2021","unstructured":"Shahidian, L. Z. et al. Succinylation of H3K122 destabilizes nucleosomes and enhances transcription. EMBO Rep. 22, e51009 (2021).","journal-title":"EMBO Rep."},{"key":"2820_CR401","doi-asserted-by":"publisher","first-page":"e50967","DOI":"10.15252\/embr.202050967","volume":"22","author":"G Yang","year":"2021","unstructured":"Yang, G. et al. Histone acetyltransferase 1 is a succinyltransferase for histones and non-histones and promotes tumorigenesis. EMBO Rep. 22, e50967 (2021).","journal-title":"EMBO Rep."},{"key":"2820_CR402","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41027-w","volume":"14","author":"L Ibrahim","year":"2023","unstructured":"Ibrahim, L. et al. Succinylation of a KEAP1 sensor lysine promotes NRF2. Nat. Commun. 14, 5320 (2023).","journal-title":"Nat. Commun."},{"key":"2820_CR403","unstructured":"K\u00fchrer, N. et al. Targeting metabolic and epigenetic reprogramming in FH-deficient tumors. Br. J. Cancer. 133, (2025)."},{"key":"2820_CR404","doi-asserted-by":"publisher","first-page":"1332049","DOI":"10.3389\/fcell.2023.1332049","volume":"12","author":"Y Song","year":"2024","unstructured":"Song, Y. et al. Post translational modifications of Keap1: the state of the art. Front. Cell Dev. Biol. 12, 1332049 (2024).","journal-title":"Front. Cell Dev. Biol."},{"key":"2820_CR405","doi-asserted-by":"crossref","unstructured":"Hou, X. et al. Dysregulation of protein succinylation and disease development. Front. Mol. Biosci. 11 (2024).","DOI":"10.3389\/fmolb.2024.1407505"},{"key":"2820_CR406","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/cancers17162652","volume":"17","author":"J Gao","year":"2025","unstructured":"Gao, J. & Yu, W. Regulators of cancer progression: succinylation. Cancers 17, 2652 (2025).","journal-title":"Cancers"},{"key":"2820_CR407","doi-asserted-by":"publisher","first-page":"20120363","DOI":"10.1098\/rstb.2012.0363","volume":"368","author":"JH Seo","year":"2013","unstructured":"Seo, J. H. et al. Deconvoluting complex tissues for expression quantitative trait locus-based analyses. Philos. Trans. R. Soc. Lond. B Biol. Sci. 368, 20120363 (2013).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"2820_CR408","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1158\/0008-5472.CAN-22-2624","volume":"83","author":"Y Liu","year":"2023","unstructured":"Liu, Y., Gusev, A. & Kraft, P. Germline cancer gene expression quantitative trait loci are associated with local and global tumor mutations. Cancer Res. 83, 1191\u20131202 (2023).","journal-title":"Cancer Res."},{"key":"2820_CR409","doi-asserted-by":"crossref","unstructured":"Lv, F. et al. eQTL and multiomics integration reveal PPIH as a prognostic and immunotherapeutic biomarker. Front. Immunol. 16, (2025).","DOI":"10.3389\/fimmu.2025.1647722"},{"key":"2820_CR410","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10549-016-3847-3","volume":"158","author":"T Koru-Sengul","year":"2016","unstructured":"Koru-Sengul, T. et al. Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to nonblack Latinas and Caucasians. Breast Cancer Res. Treat. 158, 113\u2013126 (2016).","journal-title":"Breast Cancer Res. Treat."},{"key":"2820_CR411","doi-asserted-by":"publisher","first-page":"e12560","DOI":"10.1200\/JCO.2023.41.16_suppl.e12560","volume":"41","author":"B Liu","year":"2023","unstructured":"Liu, B. et al. Prevalence and patterns of breast white adipose tissue inflammation among American Black women and indigenous Nigerian women with early-stage breast cancer. J. Clin. Oncol. 41, e12560 (2023).","journal-title":"J. Clin. Oncol."},{"key":"2820_CR412","doi-asserted-by":"publisher","first-page":"e12541","DOI":"10.1200\/JCO.2022.40.16_suppl.e12541","volume":"40","author":"N Liadis","year":"2022","unstructured":"Liadis, N. et al. Using a multimodal approach to elucidate racial disparities in breast cancer biology by integrating tumor imaging and -omics data. J. Clin. Oncol. 40, e12541 (2022).","journal-title":"J. Clin. Oncol."},{"key":"2820_CR413","doi-asserted-by":"crossref","unstructured":"Marczyk, M. et al. Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer. NPJ Breast Cancer (2022).","DOI":"10.1038\/s41523-022-00449-3"},{"key":"2820_CR414","doi-asserted-by":"crossref","unstructured":"Yang, Y. Editorial: The adipose tissue microenvironment in cancer: molecular mechanisms and targets for treatment. Front. Cell Dev. Biol. (2022).","DOI":"10.3389\/fcell.2022.954645"},{"key":"2820_CR415","doi-asserted-by":"crossref","unstructured":"Tahergorabi, Z. et al. Crosstalk between obesity and cancer: a role for adipokines. Arch. Physiol. Biochem. (2021).","DOI":"10.1080\/13813455.2021.1988110"},{"key":"2820_CR416","unstructured":"Sanhueza, S., Vergara, P. & Leyton, L. The adipocyte\u2013macrophage relationship in Cancer. Int. J. Mol. Sci. (2023)."},{"key":"2820_CR417","doi-asserted-by":"crossref","unstructured":"Yang, Z., Liu, Y. & Zhang, X. Dissecting the emerging role of cancer-associated adipocyte-derived cytokines in remodeling breast cancer progression. Front. Oncol. (2024).","DOI":"10.2139\/ssrn.4834263"},{"key":"2820_CR418","doi-asserted-by":"crossref","unstructured":"Gu, Y., Zhou, H. & Li, X. Osteopontin is a therapeutic target that drives breast cancer recurrence by recruiting and polarizing macrophages. Nat. Commun. (2024).","DOI":"10.1038\/s41467-024-53023-9"},{"key":"2820_CR419","doi-asserted-by":"crossref","unstructured":"Tang, Y., Zhang, S. & Li, J. Regulation of CD8+ T cells by lipid metabolism in cancer progression and therapy. Cell. Mol. Immunol. (2024).","DOI":"10.1038\/s41423-024-01224-z"},{"key":"2820_CR420","doi-asserted-by":"crossref","unstructured":"Xu, S., Cha, M. & Li, X. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity (2021).","DOI":"10.1016\/j.immuni.2021.05.003"},{"key":"2820_CR421","doi-asserted-by":"crossref","unstructured":"Mantovani, A., Marchesi, F. & Allavena, P. Macrophage diversity in cancer dissemination and metastasis. Cell. Mol. Immunol. (2024).","DOI":"10.1038\/s41423-024-01216-z"},{"key":"2820_CR422","unstructured":"Sun, M., Zhang, Y. & Wang, P. ALKBH5-mediated upregulation of CPT1A promotes fatty acid oxidation and M2 polarization of macrophages in colorectal cancer. Exp. Cell Res. (2024)."},{"key":"2820_CR423","doi-asserted-by":"crossref","unstructured":"Jiang, C., Zhou, B. & Liu, W. Small extracellular vesicle\u2013mediated metabolic reprogramming in the tumor microenvironment. Cell Death Discov. (2023).","DOI":"10.1186\/s12964-023-01136-x"},{"key":"2820_CR424","doi-asserted-by":"crossref","unstructured":"Chen, M. Y., Zhang, Q. & Wang, H. Dendritic cell subsets and implications for cancer immunotherapy. Front. Immunol., (2024).","DOI":"10.3389\/fimmu.2024.1393451"},{"key":"2820_CR425","doi-asserted-by":"crossref","unstructured":"Duong, L. K., Gao, J. & Hsu, B. Lipid metabolism in tumor immunology and immunotherapy. Front. Oncol. (2023).","DOI":"10.3389\/fonc.2023.1187279"},{"key":"2820_CR426","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87489","volume":"2","author":"YY Wang","year":"2017","unstructured":"Wang, Y. Y. et al. Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells. JCI Insight 2, e87489 (2017).","journal-title":"JCI Insight"},{"key":"2820_CR427","doi-asserted-by":"crossref","unstructured":"Thakir, T. M. et al. Cancer therapy and cachexia. J. Clin. Invest. 135, (2025).","DOI":"10.1172\/JCI191934"},{"key":"2820_CR428","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s43587-023-00439-5","volume":"3","author":"Y Ma","year":"2023","unstructured":"Ma, Y. & Cao, H. \u2018Lnc-ing\u2019 T(reg) cells to the aging liver. Nat. Aging 3, 760\u2013761 (2023).","journal-title":"Nat. Aging"},{"key":"2820_CR429","doi-asserted-by":"publisher","first-page":"100797","DOI":"10.1016\/j.eclinm.2021.100797","volume":"34","author":"GS Falchook","year":"2021","unstructured":"Falchook, G. S. et al. First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors. EClinicalMedicine 34, 100797 (2021).","journal-title":"EClinicalMedicine"},{"key":"2820_CR430","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1158\/1078-0432.CCR-22-2807","volume":"29","author":"W Kelly","year":"2023","unstructured":"Kelly, W. et al. Phase II investigation of TVB-2640 (denifanstat) with bevacizumab in patients with first relapse high-grade astrocytoma. Clin. Cancer Res. 29, 2419\u20132425 (2023).","journal-title":"Clin. Cancer Res."},{"key":"2820_CR431","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00656-0","volume":"10","author":"HA Serhan","year":"2024","unstructured":"Serhan, H. A. et al. Targeting fatty acid synthase in preclinical models of TNBC brain metastases synergizes with SN-38 and impairs invasion. NPJ Breast Cancer 10, 43 (2024).","journal-title":"NPJ Breast Cancer"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02820-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02820-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02820-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:02:43Z","timestamp":1787616163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02820-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":431,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2820"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02820-3","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"347"}}